[go: up one dir, main page]

JP2002012580A - Optically active compound, method for producing the same, liquid crystal composition containing the same, and liquid crystal device - Google Patents

Optically active compound, method for producing the same, liquid crystal composition containing the same, and liquid crystal device

Info

Publication number
JP2002012580A
JP2002012580A JP2001131178A JP2001131178A JP2002012580A JP 2002012580 A JP2002012580 A JP 2002012580A JP 2001131178 A JP2001131178 A JP 2001131178A JP 2001131178 A JP2001131178 A JP 2001131178A JP 2002012580 A JP2002012580 A JP 2002012580A
Authority
JP
Japan
Prior art keywords
group
oco
formula
liquid crystal
optically active
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2001131178A
Other languages
Japanese (ja)
Other versions
JP4849732B2 (en
Inventor
Takeshi Koike
毅 小池
Osamu Yokokoji
修 横小路
Satoshi Niiyama
聡 新山
Shinya Tawara
慎哉 田原
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Seimi Chemical Co Ltd
Kyocera Display Corp
AGC Inc
Original Assignee
Asahi Glass Co Ltd
Seimi Chemical Co Ltd
Kyocera Display Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asahi Glass Co Ltd, Seimi Chemical Co Ltd, Kyocera Display Corp filed Critical Asahi Glass Co Ltd
Priority to JP2001131178A priority Critical patent/JP4849732B2/en
Publication of JP2002012580A publication Critical patent/JP2002012580A/en
Application granted granted Critical
Publication of JP4849732B2 publication Critical patent/JP4849732B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Liquid Crystal Substances (AREA)

Abstract

(57)【要約】 【課題】低粘性でらせん誘起力の大きい重合性光学活性
化合物、該光学活性化合物を用いた液晶組成物、高分子
状物質および液晶素子の提供。 【解決手段】R-X1-A1-B1-C* HY1-CH2-(B2)n -X2-A2-X3-
A3-X4-Z-OCO-CY2=CH2 ただし、Rはアルキル基等、X1 、X2 、X3 、X4
単結合または−COO−等、Y1 、Y2 はメチル基また
は水素原子等、Zはアルキレン基等、A1 、A2
3 、B1 、B2 は環基を示す。
(57) [Problem] To provide a polymerizable optically active compound having a low viscosity and a large helical inducing force, a liquid crystal composition using the optically active compound, a polymer substance, and a liquid crystal element. [Solution] RX 1 -A 1 -B 1 -C * HY 1 -CH 2- (B 2 ) n -X 2 -A 2 -X 3-
A 3 -X 4 -Z-OCO-CY 2 = CH 2 where R is an alkyl group or the like, X 1 , X 2 , X 3 , X 4 is a single bond or -COO-, etc., and Y 1 and Y 2 are methyl Z is an alkylene group or the like, A 1 , A 2 ,
A 3 , B 1 and B 2 each represent a ring group.

Description

【発明の詳細な説明】DETAILED DESCRIPTION OF THE INVENTION

【0001】[0001]

【発明の属する技術分野】本発明は、液晶素子等に利用
される光学活性化合物、その中間体である光学活性化合
物、それら光学活性化合物の製造方法、該光学活性化合
物を用いた液晶組成物、該光学活性化合物を共重合させ
た高分子状物質、および該液晶組成物または該高分子状
物質を用いた液晶素子に関する。
The present invention relates to an optically active compound used for a liquid crystal device or the like, an optically active compound as an intermediate thereof, a method for producing the optically active compound, a liquid crystal composition using the optically active compound, The present invention relates to a polymer material obtained by copolymerizing the optically active compound, and a liquid crystal composition or a liquid crystal device using the polymer material.

【0002】[0002]

【従来の技術】液晶光学素子は、OA機器用表示装置、
携帯端末をはじめ、測定器、自動車用計器、家電製品用
表示装置、時計、電卓等種々の用途に使用されている。
液晶電気光学素子は、それぞれ表面に透明電極、中間保
護膜および液晶配向膜が形成された一対の透明基板を、
一定に距離を隔てて配置し、その基板間に液晶材料を封
入した構造になっており、電極から液晶材料に電圧を印
加し、液晶材料の配列状態を変化させて光学的な性質を
変えることにより、光スイッチング素子として機能して
いる。
2. Description of the Related Art A liquid crystal optical element is a display device for OA equipment,
It is used for various purposes such as portable terminals, measuring instruments, automobile instruments, display devices for home appliances, watches, calculators, and the like.
The liquid crystal electro-optical element has a pair of transparent substrates on each of which a transparent electrode, an intermediate protective film and a liquid crystal alignment film are formed,
A structure in which a liquid crystal material is sealed between the substrates at a fixed distance, and a voltage is applied from the electrodes to the liquid crystal material to change the alignment state of the liquid crystal material and change the optical properties. Thereby, it functions as an optical switching element.

【0003】ツイストネマチック(TN)型およびスー
パーツイストネマチック(STN)型液晶表示素子に
は、均一なツイスト配向を達成するために、少量(0.
5〜3質量%程度)の光学活性化合物(カイラル剤)を
添加した液晶組成物が用いられている。また、反射コレ
ステリック型液晶表示素子では、ネマチック液晶組成物
に光学活性化合物を多量(8〜60質量%程度)に添加
したコレステリック液晶組成物が用いられ、コレステリ
ック液晶が液晶材料の平均屈折率とらせんピッチの積の
波長の光を選択反射する現象を利用している。
[0003] Twisted nematic (TN) type and super twisted nematic (STN) type liquid crystal display elements have a small amount (0. 0. 1) to achieve a uniform twist alignment.
(About 5 to 3% by mass) of an optically active compound (chiral agent). In a reflective cholesteric liquid crystal display device, a cholesteric liquid crystal composition in which an optically active compound is added in a large amount (about 8 to 60% by mass) to a nematic liquid crystal composition is used. The phenomenon of selectively reflecting light having a wavelength that is the product of the pitch is used.

【0004】また、ヨーロッパ特許EP451905、
特開平7−258638号公報等には、重合した高分子
量の物質が低分子量の液晶状物質中において永久配向ネ
ットワークを形成したアニソトロピックゲル形態の液晶
状物質について記載されている。この形態は共重合可能
な光学活性化合物の重合によって収得可能となる。現在
幅広く用いられている光学活性化合物には、例えば、下
式(CN)で表される化合物、下式(S−811)で表
される化合物、または下式(CB−15)で表される化
合物などがある。
[0004] Also, European Patent EP451905,
Japanese Patent Application Laid-Open No. 7-258638 and the like disclose an anisotropic gel-like liquid crystal material in which a polymerized high molecular weight material forms a permanent alignment network in a low molecular weight liquid crystal material. This form can be obtained by polymerization of a copolymerizable optically active compound. Currently widely used optically active compounds include, for example, a compound represented by the following formula (CN), a compound represented by the following formula (S-811), or a compound represented by the following formula (CB-15) Compounds.

【0005】[0005]

【化1】 Embedded image

【0006】液晶組成物に光学活性化合物を添加した時
に誘起されるヘリカルピッチ長は、化合物固有のらせん
誘起力によって決まり、また、添加量にほぼ比例する。
らせん誘起力が小さい光学活性化合物ほど、誘起される
ヘリカルピッチ長が長く、ヘリカルピッチ長を短くした
い時には、添加量を多くしなければならない。一般に、
光学活性化合物の添加量を多くすると、添加前と比較し
て、液晶材料としての性能は低下し、粘度の上昇、応答
速度の低下、駆動電圧の上昇、等方相転移温度の低下、
ネマチック相、コレステリック相またはスメクチック相
などの特定の相を示す温度範囲の縮小などの問題が生じ
る。したがって、らせん誘起力の大きな光学活性化合物
が要求されている。
The helical pitch length induced when an optically active compound is added to a liquid crystal composition is determined by the helical inducing force inherent to the compound, and is almost proportional to the amount added.
The smaller the optically active compound has a helical inducing force, the longer the induced helical pitch length is. When it is desired to shorten the helical pitch length, the amount of addition must be increased. In general,
When the addition amount of the optically active compound is increased, the performance as a liquid crystal material is reduced as compared with before addition, the viscosity is increased, the response speed is reduced, the driving voltage is increased, the isotropic phase transition temperature is reduced,
Problems arise, such as a reduction in the temperature range exhibiting a particular phase, such as a nematic phase, a cholesteric phase, or a smectic phase. Therefore, an optically active compound having a large helical inducing force is required.

【0007】[0007]

【発明が解決しようとする課題】本発明の目的は、種々
の光学的製品に使用できる液晶素子、液晶フィルム等に
有用な光学活性化合物、その中間体となる光学活性化合
物、それらの光学活性化合物を高収率で容易に製造でき
る製造方法、該光学活性化合物を用いた液晶組成物、該
光学活性化合物を共重合させた高分子状物質、および該
液晶組成物または該高分子状物質を用いた液晶素子の提
供にある。
SUMMARY OF THE INVENTION An object of the present invention is to provide an optically active compound useful for liquid crystal devices and liquid crystal films which can be used for various optical products, an optically active compound as an intermediate thereof, and those optically active compounds. Method, which can be easily produced at a high yield, a liquid crystal composition using the optically active compound, a polymer material obtained by copolymerizing the optically active compound, and a liquid crystal composition or the polymer material. To provide a liquid crystal device.

【0008】[0008]

【課題を解決するための手段】すなわち、本発明は下式
(1)で表される光学活性化合物を提供する。 R-X1-A1-B1-C* HY1-CH2-(B2)n -X2-A2-X3-A3-X4-Z-OCO-CY2=CH2 …式(1) ただし、式(1)中の記号は下記の意味を示す。 R:炭素数1〜12のアルキル基、水素原子の1個以上
がフッ素原子に置換された炭素数1〜12のアルキル
基、水素原子またはハロゲン原子。 X1 、X2 、X3 、X4 :相互に独立して、カルボニル
オキシ基(−COO−)、オキシカルボニル基(−OC
O−)、エーテル性の酸素原子(−O−)、オキシメチ
レン基(−OCH2 −)、メチレンオキシ基(−CH2
O−)または単結合。 Y1 :メチル基(−CH3 )または水素原子の1個以上
がフッ素原子に置換されたメチル基。 Y2 :水素原子またはメチル基(−CH3 )。
That is, the present invention provides an optically active compound represented by the following formula (1). RX 1 -A 1 -B 1 -C * HY 1 -CH 2- (B 2 ) n -X 2 -A 2 -X 3 -A 3 -X 4 -Z-OCO-CY 2 = CH 2 … 1) However, the symbols in the formula (1) have the following meanings. R: an alkyl group having 1 to 12 carbon atoms, an alkyl group having 1 to 12 carbon atoms in which at least one hydrogen atom is substituted with a fluorine atom, a hydrogen atom or a halogen atom. X 1 , X 2 , X 3 , X 4 : independently of each other, a carbonyloxy group (—COO—), an oxycarbonyl group (—OC
O-), etheric oxygen atom (-O-), oxymethylene group (-OCH 2 -), a methylene group (-CH 2
O-) or a single bond. Y 1 : a methyl group (—CH 3 ) or a methyl group in which at least one hydrogen atom has been replaced by a fluorine atom. Y 2 : a hydrogen atom or a methyl group (—CH 3 ).

【0009】Z:炭素数1〜12のアルキレン基または
水素原子の1個以上がフッ素原子に置換された炭素数1
〜12のアルキレン基。 A1 、A2 、A3 :相互に独立して、水素原子の1個ま
たは2個がフッ素原子に置換されていてもよい1,4−
フェニレン基、水素原子の1個または2個がメチル基
(−CH3 )に置換されていてもよい1,4−フェニレ
ン基、非置換の2,6−ナフチレン基、非置換のトラン
ス−1,4−シクロヘキシレン基または単結合。 B1 、B2 :相互に独立して、水素原子の1個もしくは
2個がフッ素原子に置換されていてもよい1,4−フェ
ニレン基、水素原子の1個もしくは2個がメチル基(−
CH3 )に置換されていてもよい1,4−フェニレン
基、非置換の2,6−ナフチレン基、非置換のトランス
−1,4−シクロヘキシレン基または−D 1 −CH2
2 −D2 −で表される基(D1 およびD2 はそれぞれ
独立に、水素原子の1個または2個がフッ素原子および
/またはメチル基(−CH3 )に置換されていてもよい
1,4−フェニレン基、非置換の2,6−ナフチレン
基、非置換のトランス−1,4−シクロヘキシレン基を
表す。)。 n:1または2。 C* :不斉炭素原子。
Z: an alkylene group having 1 to 12 carbon atoms or
1 carbon atom in which at least one hydrogen atom has been replaced by a fluorine atom
~ 12 alkylene groups. A1, ATwo, AThree: Up to one hydrogen atom independently of each other
Or two of which may be substituted with a fluorine atom
Phenylene group, one or two hydrogen atoms are methyl groups
(-CHThree1,4-phenylene optionally substituted by
Group, unsubstituted 2,6-naphthylene group, unsubstituted
1,4-cyclohexylene group or single bond. B1, BTwo: Independently of one another,
1,4-phenyl optionally substituted by two fluorine atoms
Nylene group, one or two hydrogen atoms are methyl group (-
CHThree1,4-phenylene optionally substituted by
Group, unsubstituted 2,6-naphthylene group, unsubstituted trans
-1,4-cyclohexylene group or -D 1-CHTwoC
HTwo-DTwoA group represented by-(D1And DTwoAre each
Independently, one or two of the hydrogen atoms are a fluorine atom and
And / or methyl group (-CHThree) May be substituted
1,4-phenylene group, unsubstituted 2,6-naphthylene
Group, unsubstituted trans-1,4-cyclohexylene group
Represent. ). n: 1 or 2. C*: Asymmetric carbon atom.

【0010】式(1)で表される化合物が下式(2)で
表される化合物であることが好ましい。 R-X1-A1-B1-C* HY1-CH2-(B2)n -COO-A2-X3-A3-X4-Z-OCO-CY2=CH2 …式(2) ただし、式(2)中の記号R、X1 、X3 、X4
1 、Y2 、Z、A1 、A2、A3 、B1 、B2 、nお
よびC* は式(1)におけるものと同じ意味を示す。
The compound represented by the formula (1) is preferably a compound represented by the following formula (2). RX 1 -A 1 -B 1 -C * HY 1 -CH 2- (B 2 ) n -COO-A 2 -X 3 -A 3 -X 4 -Z-OCO-CY 2 = CH 2 … Formula (2) Where the symbols R, X 1 , X 3 , X 4 ,
Y 1 , Y 2 , Z, A 1 , A 2 , A 3 , B 1 , B 2 , n and C * have the same meanings as in formula (1).

【0011】また、本発明は下式(3)で表される光学
活性化合物を提供する。 R-X1-A1-B1-C* HY1-CH2-(B2)n -COOH …式(3) ただし、式(3)中の記号R、X1 、Y1 、A1
1 、B2 、nおよびC* は式(1)におけるものと同
じ意味を示す。
Further, the present invention provides an optically active compound represented by the following formula (3). RX 1 -A 1 -B 1 -C * HY 1 -CH 2- (B 2 ) n -COOH Formula (3) where symbols R, X 1 , Y 1 , A 1 ,
B 1 , B 2 , n and C * have the same meaning as in formula (1).

【0012】また、本発明は下記の工程(a)および工
程(b)を経由する式(3)で表される光学活性化合物
の製造方法を提供する。 工程(a):下式(4)で表されるカルボン酸を酸クロ
ライドとし、下式(5)で表されるグリニャール試薬と
カップリング反応させ、生成した下式(6)で表される
ケトンを還元し、下式(7)で表される光学活性化合物
とする工程。 工程(b):下式(7)で表される光学活性化合物を下
式(8)で表されるグリニャール試薬とし、二酸化炭素
と反応させる工程。 R-X1-A1-B1-C* HY1-COOH …式(4) Q'-Mg-(B2)n -Q …式(5) R-X1-A1-B1-C* HY1-CO- (B2)n -Q …式(6) R-X1-A1-B1-C* HY1-CH2-(B2)n -Q …式(7) R-X1-A1-B1-C* HY1-CH2-(B2)n -Mg-Q …式(8) ただし、式(4)、(5)、(6)、(7)および
(8)中のR、X1 、Y1 、A1 、B1 、B2 、nおよ
びC* は、式(3)におけるものと同じ意味を示し、Q
およびQ’は下記の意味を示す。 Q:ハロゲン原子。 Q’:臭素原子またはヨウ素原子。 ただし、Q’が臭素原子の場合、Qはヨウ素原子ではな
い。
The present invention also provides a method for producing an optically active compound represented by the formula (3) via the following steps (a) and (b). Step (a): A carboxylic acid represented by the following formula (4) is converted to an acid chloride, and a coupling reaction is performed with a Grignard reagent represented by the following formula (5) to produce a ketone represented by the following formula (6): To obtain an optically active compound represented by the following formula (7). Step (b): a step of converting an optically active compound represented by the following formula (7) into a Grignard reagent represented by the following formula (8) and reacting with carbon dioxide. RX 1 -A 1 -B 1 -C * HY 1 -COOH ... Equation (4) Q'-Mg- (B 2 ) n -Q ... Equation (5) RX 1 -A 1 -B 1 -C * HY 1 -CO- (B 2 ) n -Q… Equation (6) RX 1 -A 1 -B 1 -C * HY 1 -CH 2- (B 2 ) n -Q… Equation (7) RX 1 -A 1- B 1 -C * HY 1 -CH 2- (B 2 ) n -Mg-Q where R in the formulas (4), (5), (6), (7) and (8) , X 1 , Y 1 , A 1 , B 1 , B 2 , n and C * have the same meanings as in formula (3),
And Q ′ have the following meanings. Q: a halogen atom. Q ′: a bromine atom or an iodine atom. However, when Q ′ is a bromine atom, Q is not an iodine atom.

【0013】また、本発明は式(3)で表される光学活
性化合物を酸クロライドとし、下式(9)で表されるア
ルコールと反応させることを特徴とする式(2)で表さ
れる光学活性化合物の製造方法を提供する。 HO-A2-X3-A3-X4-Z-OCO-CY2=CH2 …式(9) ただし、式(9)中のX3 、X4 、A2 、A3 、Y2
よびZは式(2)におけるものと同じ意味を示す。
In the present invention, the optically active compound represented by the formula (3) is converted to an acid chloride and reacted with an alcohol represented by the following formula (9). Provided is a method for producing an optically active compound. HO-A 2 -X 3 -A 3 -X 4 -Z-OCO-CY 2 = CH 2 Formula (9) where X 3 , X 4 , A 2 , A 3 and Y 2 in the formula (9) And Z have the same meaning as in formula (2).

【0014】さらに、本発明は式(1)または(2)で
表される光学活性化合物の1種以上を、合量で0.1〜
80質量%含有する液晶組成物、および該液晶組成物を
用いた液晶素子を提供する。また、本発明は式(1)ま
たは(2)で表される光学活性化合物の1種以上を共重
合させた高分子状物質を提供する。さらに、本発明は該
高分子状物質を用いた液晶素子を提供する。
Further, the present invention relates to a method for preparing one or more optically active compounds represented by the formula (1) or (2) in a total amount of 0.1 to
Provided is a liquid crystal composition containing 80% by mass, and a liquid crystal element using the liquid crystal composition. The present invention also provides a polymeric substance obtained by copolymerizing at least one optically active compound represented by the formula (1) or (2). Further, the present invention provides a liquid crystal device using the polymer.

【0015】[0015]

【発明の実施の形態】[式の説明]以下において、式
(1)で表される化合物を化合物(1)とも記載する。
化合物(2)などの表記についても同様である。また、
本明細書を通じて、C3 7-、C6 13- などは直鎖ア
ルキル基を示す。 -CH2-、 -C6 12- などは直鎖ア
ルキレン基を示す。 -CO- はカルボニル基(>C=
O)を示す。式(1)または(2)で表される化合物
は、その構造中に不斉炭素原子(C*)を含む光学活性
な化合物である。不斉炭素原子に結合する基の絶対配置
はR体またはS体のいずれであってもよい。
BEST MODE FOR CARRYING OUT THE INVENTION [Description of Formula] Hereinafter, the compound represented by the formula (1) is also described as a compound (1).
The same applies to the notation of the compound (2) and the like. Also,
Throughout this specification, C 3 H 7- , C 6 H 13- and the like indicate a straight-chain alkyl group. -CH 2- , -C 6 H 12- and the like represent a linear alkylene group. -CO- is a carbonyl group (> C =
O). The compound represented by the formula (1) or (2) is an optically active compound containing an asymmetric carbon atom (C * ) in its structure. The absolute configuration of the group bonded to the asymmetric carbon atom may be either R-form or S-form.

【0016】化合物(1)〜(9)において、Rは炭素
数1〜12のアルキル基、水素原子の1個以上がフッ素
原子に置換された炭素数1〜12のアルキル基、水素原
子またはハロゲン原子である。アルキル基は直鎖であっ
ても、枝分かれがあってもよく、枝分かれがある場合
は、その構造中に不斉炭素原子を含んでいてもよい。炭
素数1〜12のアルキル基としては、メチル基、エチル
基、プロピル基、イソプロピル基、ブチル基、2−メチ
ルプロピル基、sec−ブチル基、tert−ブチル
基、ペンチル基、イソペンチル基、ネオペンチル基、t
ert−ペンチル基、1−メチルブチル基、2−メチル
ブチル基、1,2−ジメチルプロピル基、ヘキシル基、
イソヘキシル基、1−メチルペンチル基、2−メチルペ
ンチル基、3−メチルペンチル基、1,1−ジメチルブ
チル基、1,2−ジメチルブチル基、2,2−ジメチル
ブチル基、1,3−ジメチルブチル基、2,3−ジメチ
ルブチル基、3,3−ジメチルブチル基、1−エチルブ
チル基、2−エチルブチル基、1,1,2−トリメチル
プロピル基、1,2,2−トリメチルプロピル基、1−
エチル−1−メチルプロピル基、1−エチル−2−メチ
ルプロピル基等が挙げられる。また、これらの基が二重
結合や三重結合を含んでいるものも含まれる。これらの
なかでも、Rとしては、炭素数3〜6のアルキル基また
は水素原子が好ましく、原料の入手しやすさの観点か
ら、2−メチルプロピル基(CH3-CH(CH3)-CH2-)、水素原
子が特に好ましい。
In the compounds (1) to (9), R represents an alkyl group having 1 to 12 carbon atoms, an alkyl group having 1 to 12 carbon atoms in which at least one hydrogen atom is substituted by a fluorine atom, a hydrogen atom or a halogen atom. Is an atom. The alkyl group may be straight-chain or branched, and when branched, may have an asymmetric carbon atom in its structure. Examples of the alkyl group having 1 to 12 carbon atoms include methyl, ethyl, propyl, isopropyl, butyl, 2-methylpropyl, sec-butyl, tert-butyl, pentyl, isopentyl, and neopentyl. , T
ert-pentyl group, 1-methylbutyl group, 2-methylbutyl group, 1,2-dimethylpropyl group, hexyl group,
Isohexyl group, 1-methylpentyl group, 2-methylpentyl group, 3-methylpentyl group, 1,1-dimethylbutyl group, 1,2-dimethylbutyl group, 2,2-dimethylbutyl group, 1,3-dimethyl Butyl group, 2,3-dimethylbutyl group, 3,3-dimethylbutyl group, 1-ethylbutyl group, 2-ethylbutyl group, 1,1,2-trimethylpropyl group, 1,2,2-trimethylpropyl group, 1 −
Examples thereof include an ethyl-1-methylpropyl group and a 1-ethyl-2-methylpropyl group. In addition, those in which these groups contain a double bond or a triple bond are also included. Among these, as R, an alkyl group having 3 to 6 carbon atoms or a hydrogen atom is preferable, and from the viewpoint of availability of raw materials, a 2-methylpropyl group (CH 3 —CH (CH 3 ) —CH 2 -), And a hydrogen atom is particularly preferred.

【0017】X1 、X2 、X3 およびX4 は、相互に独
立して、カルボニルオキシ基(−COO−)、オキシカ
ルボニル基(−OCO−)、エーテル性の酸素原子(−
O−)、オキシメチレン基(−OCH2 −)、メチレン
オキシ基(−CH2 O−)または単結合である。X1
2 、X3 およびX4 は、同一であっても異なっていて
もよい。X1 は、エーテル性の酸素原子または単結合が
好ましく、特に単結合が好ましい。X2 、X3 およびX
4 は、カルボニルオキシ基、エーテル性の酸素原子また
は単結合が好ましく、特にX2 はカルボニルオキシ基が
好ましい。また、式(1)において、X2 がエーテル性
の酸素原子であって、X3 およびX4 が単結合である場
合、または式(2)において、X3 およびX4 が単結合
である場合が好ましい。
X 1 , X 2 , X 3 and X 4 each independently represent a carbonyloxy group (—COO—), an oxycarbonyl group (—OCO—), an etheric oxygen atom (—
O-), oxymethylene group (-OCH 2 -), a methylene group (-CH 2 O-) or a single bond. X 1 ,
X 2 , X 3 and X 4 may be the same or different. X 1 is preferably an etheric oxygen atom or a single bond, particularly preferably a single bond. X 2 , X 3 and X
4 is preferably a carbonyloxy group, an etheric oxygen atom or a single bond, and particularly preferably X 2 is a carbonyloxy group. In the formula (1), when X 2 is an etheric oxygen atom and X 3 and X 4 are a single bond, or in the formula (2), X 3 and X 4 are a single bond Is preferred.

【0018】Y1 はメチル基(−CH3 )または水素原
子の1個以上がフッ素原子に置換されたメチル基であ
る。Y1 としては、メチル基またはトリフルオロメチル
基が好ましく、特にメチル基が好ましい。Y2 は水素原
子またはメチル基(−CH3 )であり、水素原子が好ま
しい。Zは炭素数1〜12のアルキレン基、または水素
原子の1個以上がフッ素原子に置換された炭素数1〜1
2のアルキレン基である。アルキレン基は直鎖であって
も、枝分かれがあってもよく、枝分かれがある場合はそ
の構造中に不斉炭素原子を含んでいてもよい。炭素数1
〜12のアルキレン基としては、上述の炭素数1〜12
のアルキル基から、水素原子が1個失われて生ずる2価
の基が例示される。これらのなかでも、Zとしては、炭
素数2〜6のアルキレン基が好ましく、炭素数2〜6の
直鎖のアルキレン基が特に好ましい。
Y 1 is a methyl group (—CH 3 ) or a methyl group in which one or more hydrogen atoms have been replaced by fluorine atoms. Y 1 is preferably a methyl group or a trifluoromethyl group, particularly preferably a methyl group. Y 2 is a hydrogen atom or a methyl group (—CH 3 ), and a hydrogen atom is preferable. Z represents an alkylene group having 1 to 12 carbon atoms, or a carbon atom having 1 to 1 carbon atoms in which at least one hydrogen atom is substituted by a fluorine atom
2 alkylene groups. The alkylene group may be linear or branched, and if branched, may have an asymmetric carbon atom in its structure. Carbon number 1
Examples of the alkylene group having 1 to 12 carbon atoms include the above-described 1 to 12 carbon atoms.
And a divalent group generated by losing one hydrogen atom from the above alkyl group. Among them, Z is preferably an alkylene group having 2 to 6 carbon atoms, and particularly preferably a linear alkylene group having 2 to 6 carbon atoms.

【0019】A1 、A2 およびA3 は、相互に独立し
て、水素原子の1個または2個がフッ素原子に置換され
ていてもよい1,4−フェニレン基、水素原子の1個ま
たは2個がメチル基(−CH3 )に置換されていてもよ
い1,4−フェニレン基、非置換の2,6−ナフチレン
基、非置換のトランス−1,4−シクロヘキシレン基ま
たは単結合である。A1 、A2 およびA3 は、同一であ
っても異なっていてもよい。A1 は非置換の1,4−フ
ェニレン基または単結合が好ましく、単結合が特に好ま
しい。A2 およびA3 は非置換の1,4−フェニレン基
または単結合が好ましく、特に、A2 およびA3 のうち
一方が1,4−フェニレン基であり、かつもう一方が単
結合である場合、またはA2 およびA3 が共に単結合で
ある場合が好ましい。
A 1 , A 2 and A 3 each independently represent a 1,4-phenylene group in which one or two hydrogen atoms may be substituted by a fluorine atom, one hydrogen atom or A 1,4-phenylene group, an unsubstituted 2,6-naphthylene group, an unsubstituted trans-1,4-cyclohexylene group or a single bond, two of which may be substituted with a methyl group (—CH 3 ); is there. A 1 , A 2 and A 3 may be the same or different. A 1 is preferably an unsubstituted 1,4-phenylene group or a single bond, and particularly preferably a single bond. A 2 and A 3 are preferably an unsubstituted 1,4-phenylene group or a single bond, particularly when one of A 2 and A 3 is a 1,4-phenylene group and the other is a single bond Or the case where both A 2 and A 3 are a single bond.

【0020】B1 、B2 :相互に独立して、水素原子の
1個もしくは2個がフッ素原子に置換されていてもよい
1,4−フェニレン基、水素原子の1個もしくは2個が
メチル基(−CH3 )に置換されていてもよい1,4−
フェニレン基、非置換の2,6−ナフチレン基、非置換
のトランス−1,4−シクロヘキシレン基または−D 1
−CH2 CH2 −D2 −で表される基(D1 およびD2
はそれぞれ独立に、水素原子の1個または2個がフッ素
原子および/またはメチル基(−CH3 )に置換されて
いてもよい1,4−フェニレン基、非置換の2,6−ナ
フチレン基、非置換のトランス−1,4−シクロヘキシ
レン基を表す。)である。これらのなかでも、水素原子
の1個または2個がフッ素原子に置換された1,4−フ
ェニレン基または非置換の2,6−ナフチレン基が好ま
しく、水素原子の1個がフッ素原子に置換された1,4
−フェニレン基が特に好ましい。nは1または2であ
る。nが2の場合には、B2 は同じであっても異なって
いてもよい。nは1が好ましい。
B1, BTwo: Independently of each other
One or two may be substituted with a fluorine atom
1,4-phenylene group, one or two hydrogen atoms
Methyl group (-CHThree1,4-) which may be substituted
Phenylene group, unsubstituted 2,6-naphthylene group, unsubstituted
Trans-1,4-cyclohexylene group or -D 1
-CHTwoCHTwo-DTwoA group represented by-(D1And DTwo
Is each independently one or two hydrogen atoms
Atom and / or methyl group (-CHThree)
1,4-phenylene group, unsubstituted 2,6-na
Butylene group, unsubstituted trans-1,4-cyclohexyl
Represents a len group. ). Among them, hydrogen atom
Is a 1,4-phenyl group in which one or two of
A phenylene group or an unsubstituted 2,6-naphthylene group is preferred.
1,4 in which one of the hydrogen atoms is replaced by a fluorine atom
-A phenylene group is particularly preferred. n is 1 or 2
You. If n is 2, BTwoAre the same but different
May be. n is preferably 1.

【0021】以下に式(1)および(2)について、そ
れぞれ具体例を示す。なお、置換または非置換の、1,
4−フェニレン基、トランス−1,4−シクロヘキシレ
ン基および2,6−ナフチレン基を総称して「環基」と
記載する。置換または非置換の2,6−ナフチレン基は
1環基として数える。本明細書を通じて、Phは非置換
の1,4−フェニレン基、PhF はモノフルオロ−1,
4−フェニレン基、PhFFはジフルオロ−1,4−フェ
ニレン基、PhM はモノメチル−1,4−フェニレン
基、Cyは非置換のトランス−1,4−シクロヘキシレ
ン基、Npは非置換の2,6−ナフチレン基を示す。フ
ッ素原子またはメチル基の置換位置は特に限定されな
い。
Specific examples of the formulas (1) and (2) are shown below. In addition, substituted or unsubstituted 1,
A 4-phenylene group, a trans-1,4-cyclohexylene group and a 2,6-naphthylene group are generically described as a "ring group". A substituted or unsubstituted 2,6-naphthylene group is counted as one ring group. Throughout this specification, Ph is an unsubstituted 1,4-phenylene group, and Ph F is monofluoro-1,1.
4-phenylene group, Ph FF difluoro-1,4-phenylene group, Ph M is monomethyl-1,4-phenylene group, Cy is an unsubstituted trans-1,4-cyclohexylene group, Np is unsubstituted 2 , 6-naphthylene group. The substitution position of a fluorine atom or a methyl group is not particularly limited.

【0022】[式(1)が示す化合物の具体例]以下に
化合物(1)の具体例を、環基の数により分類し、順に
示す。環基の数は2、3または4個が好ましく、2また
は3個が特に好ましい。環基を2個有する化合物として
は、下記化合物が好ましく挙げられる。 H-Ph-C* H(CH3)-CH2-Ph-COO-C2H4-OCO-CH=CH2 H-Ph-C* H(CH3)-CH2-Ph-COO-C3H6-OCO-CH=CH2 H-Ph-C* H(CH3)-CH2-Ph-COO-C4H8-OCO-CH=CH2 H-Ph-C* H(CH3)-CH2-Ph-COO-C5H10-OCO-CH=CH2 H-Ph-C* H(CH3)-CH2-Ph-COO-C6H12-OCO-CH=CH2 H-Ph-C* H(CH3)-CH2-Ph-COO-C11H22-OCO-CH=CH2 H-Ph-C* H(CH3)-CH2-Ph-COO-C12H24-OCO-CH=CH2 H-Ph-C* H(CH3)-CH2- PhF -COO-C6H12-OCO-CH=CH2 H-Ph-C* H(CH3)-CH2- PhFF-COO-C6H12-OCO-CH=CH2 H-Ph-C* H(CH3)-CH2- PhM -COO-C6H12-OCO-CH=CH2 H-Ph-C* H(CH3)-CH2-Ph-O-C6H12-OCO-CH=CH2 H-Ph-C* H(CH3)-CH2- PhF -O-C6H12-OCO-CH=CH2 H-Ph-C* H(CH3)-CH2- PhFF-O-C6H12-OCO-CH=CH2 H-Ph-C* H(CH3)-CH2- PhM -O-C6H12-OCO-CH=CH2 H-Ph-C* H(CF3)-CH2-Ph-COO-C6H12-OCO-CH=CH2 H-Ph-C* H(CF3)-CH2-Ph-O-C6H12-OCO-CH=CH2 H-Ph-C* H(CH3)-CH2-Ph-COO-C6F12-OCO-CH=CH2 H-Ph-C* H(CH3)-CH2-Ph-O-C6F12-OCO-CH=CH2 H-Ph-C* H(CH3)-CH2-Ph-COO-C5H10-C5F10-OCO-CH=CH2 H-Ph-C* H(CH3)-CH2-Ph-O-C5H10-C5F10-OCO-CH=CH2 H-Ph-C* H(CH3)-CH2-Ph-COO-C5F10-C5H10-OCO-CH=CH2 H-Ph-C* H(CH3)-CH2-Ph-O-C5F10-C5H10-OCO-CH=CH2 H-Ph-C* H(CH3)-CH2-Ph-COO-C2H4-OCO-C(CH3)=CH2 H-Ph-C* H(CH3)-CH2-Ph-COO-C4H8-OCO-C(CH3)=CH2 H-Ph-C* H(CH3)-CH2-Ph-COO-C6H12-OCO-C(CH3)=CH2 H-Ph-C* H(CH3)-CH2-Ph-O-C6H12-OCO-C(CH3)=CH2 CH3-CH(CH3)-CH2-Ph-C* H(CH3)-CH2-Ph-COO-C2H4-OCO-C
H=CH2 CH3-CH(CH3)-CH2-Ph-C* H(CH3)-CH2-Ph-COO-C4H8-OCO-C
H=CH2 CH3-CH(CH3)-CH2-Ph-C* H(CH3)-CH2-Ph-COO-C6H12-OCO-
CH=CH2 CH3-CH(CH3)-CH2-Ph-C* H(CH3)-CH2-Ph-COO-C11H22-OCO
-CH=CH2 CH3-CH(CH3)-CH2-Ph-C* H(CH3)-CH2- PhF -COO-C6H12-O
CO-CH=CH2 CH3-CH(CH3)-CH2-Ph-C* H(CH3)-CH2- PhFF-COO-C6H12-O
CO-CH=CH2 CH3-CH(CH3)-CH2-Ph-C* H(CH3)-CH2- PhM -COO-C6H12-O
CO-CH=CH2 CH3-CH(CH3)-CH2-Ph-C* H(CH3)-CH2- PhF -O-C6H12-OCO
-CH=CH2 CH3-CH(CH3)-CH2-Ph-C* H(CH3)-CH2- PhM -O-C6H12-OCO
-CH=CH2 CH3-CH(CH3)-CH2-Ph-C* H(CH3)-CH2-Ph-COO-C6F12-OCO-
CH=CH2 CH3-CH(CH3)-CH2-Ph-C* H(CH3)-CH2-Ph-O-C6F12-OCO-CH
=CH2 CH3-CH(CH3)-CH2-Ph-C* H(CH3)-CH2-Ph-COO-C2H4-OCO-C
(CH3)=CH2 CH3-CH(CH3)-CH2-Ph-C* H(CH3)-CH2-Ph-COO-C4H8-OCO-C
(CH3)=CH2 CH3-CH(CH3)-CH2-Ph-C* H(CH3)-CH2-Ph-COO-C6H12-OCO-
C(CH3)=CH2 CH3-CH(CH3)-CH2-Ph-C* H(CH3)-CH2-Ph-O-C6H12-OCO-C
(CH3)=CH2 C6H13-O-Ph-C* H(CH3)-CH2-Ph-COO-C6H12-OCO-CH=CH2 C6H13-O-Ph-C* H(CH3)-CH2-Ph-O-C6H12-OCO-CH=CH2 C6H13- C* H(CH3)-O-Ph- C* H(CH3)-CH2-Ph-COO-C6H12-
OCO-CH=CH2 C6H13- C* H(CH3)-O-Ph- C* H(CH3)-CH2-Ph-O-C6H12-OC
O-C(CH3)=CH2 C5F10-CH2O-Ph- C* H(CH3)-CH2-Ph-COO-C6H12-OCO-CH=C
H2 C5F10-CH2O-Ph- C* H(CH3)-CH2-Ph-O-C6H12-OCO-CH=CH2 CH3-O-Np-C* H(CH3)-CH2-Ph-COO-C6H12-OCO-CH=CH2 CH3-O-Np-C* H(CH3)-CH2-Ph-O-C6H12-OCO-CH=CH2
[Specific examples of the compound represented by the formula (1)] Specific examples of the compound (1) are shown below, classified according to the number of ring groups. The number of ring groups is preferably 2, 3 or 4, particularly preferably 2 or 3. Preferred examples of the compound having two ring groups include the following compounds. H-Ph-C * H (CH 3 ) -CH 2 -Ph-COO-C 2 H 4 -OCO-CH = CH 2 H-Ph-C * H (CH 3 ) -CH 2 -Ph-COO-C 3 H 6 -OCO-CH = CH 2 H-Ph-C * H (CH 3 ) -CH 2 -Ph-COO-C 4 H 8 -OCO-CH = CH 2 H-Ph-C * H (CH 3 ) -CH 2 -Ph-COO-C 5 H 10 -OCO-CH = CH 2 H-Ph-C * H (CH 3 ) -CH 2 -Ph-COO-C 6 H 12 -OCO-CH = CH 2 H-Ph-C * H (CH 3 ) -CH 2 -Ph-COO-C 11 H 22 -OCO-CH = CH 2 H-Ph-C * H (CH 3 ) -CH 2 -Ph-COO-C 12 H 24 -OCO-CH = CH 2 H-Ph-C * H (CH 3 ) -CH 2 -Ph F -COO-C 6 H 12 -OCO-CH = CH 2 H-Ph-C * H (CH 3 ) -CH 2 -Ph FF -COO-C 6 H 12 -OCO-CH = CH 2 H-Ph-C * H (CH 3 ) -CH 2 -Ph M -COO-C 6 H 12 -OCO-CH = CH 2 H-Ph-C * H (CH 3 ) -CH 2 -Ph-OC 6 H 12 -OCO-CH = CH 2 H-Ph-C * H (CH 3 ) -CH 2 -Ph F -OC 6 H 12 -OCO-CH = CH 2 H-Ph-C * H (CH 3 ) -CH 2 -Ph FF -OC 6 H 12 -OCO-CH = CH 2 H-Ph-C * H (CH 3 ) -CH 2 -Ph M -OC 6 H 12 -OCO-CH = CH 2 H-Ph-C * H (CF 3 ) -CH 2 -Ph-COO-C 6 H 12 -OCO-CH = CH 2 H- Ph-C * H (CF 3 ) -CH 2 -Ph-OC 6 H 12 -OCO-CH = CH 2 H-Ph-C * H (CH 3) -CH 2 -Ph-COO-C 6 F 12 - OCO-CH = CH 2 H-Ph-C * H (CH 3 ) -CH 2 -Ph-OC 6 F 12 -OCO-CH = CH 2 H-Ph-C * H (CH 3 ) -CH 2 -Ph -COO-C 5 H 10 -C 5 F 10 -OCO-CH = CH 2 H-Ph-C * H (CH 3 ) -CH 2 -Ph-OC 5 H 10 -C 5 F 10 -OCO-CH = CH 2 H-Ph-C * H (CH 3 ) -CH 2 -Ph-COO-C 5 F 10 -C 5 H 10 -OCO-CH = CH 2 H-Ph-C * H (CH 3 ) -CH 2 -Ph-OC 5 F 10 -C 5 H 10 -OCO-CH = CH 2 H-Ph-C * H (CH 3 ) -CH 2 -Ph-COO-C 2 H 4 -OCO-C (CH 3 ) = CH 2 H-Ph -C * H (CH 3) -CH 2 -Ph-COO-C 4 H 8 -OCO-C (CH 3) = CH 2 H-Ph-C * H (CH 3) -CH 2 -Ph-COO- C 6 H 12 -OCO-C (CH 3 ) = CH 2 H-Ph-C * H (CH 3 ) -CH 2 -Ph-OC 6 H 12 -OCO-C (CH 3 ) = CH 2 CH 3- CH (CH 3 ) -CH 2 -Ph-C * H (CH 3 ) -CH 2 -Ph-COO-C 2 H 4 -OCO-C
H = CH 2 CH 3 -CH (CH 3 ) -CH 2 -Ph-C * H (CH 3 ) -CH 2 -Ph-COO-C 4 H 8 -OCO-C
H = CH 2 CH 3 -CH (CH 3 ) -CH 2 -Ph-C * H (CH 3 ) -CH 2 -Ph-COO-C 6 H 12 -OCO-
CH = CH 2 CH 3 -CH (CH 3 ) -CH 2 -Ph-C * H (CH 3 ) -CH 2 -Ph-COO-C 11 H 22 -OCO
-CH = CH 2 CH 3 -CH (CH 3 ) -CH 2 -Ph-C * H (CH 3 ) -CH 2 -Ph F -COO-C 6 H 12 -O
CO-CH = CH 2 CH 3 -CH (CH 3 ) -CH 2 -Ph-C * H (CH 3 ) -CH 2 -Ph FF -COO-C 6 H 12 -O
CO-CH = CH 2 CH 3 -CH (CH 3 ) -CH 2 -Ph-C * H (CH 3 ) -CH 2 -Ph M -COO-C 6 H 12 -O
CO-CH = CH 2 CH 3 -CH (CH 3 ) -CH 2 -Ph-C * H (CH 3 ) -CH 2 -Ph F -OC 6 H 12 -OCO
-CH = CH 2 CH 3 -CH (CH 3 ) -CH 2 -Ph-C * H (CH 3 ) -CH 2 -Ph M -OC 6 H 12 -OCO
-CH = CH 2 CH 3 -CH (CH 3 ) -CH 2 -Ph-C * H (CH 3 ) -CH 2 -Ph-COO-C 6 F 12 -OCO-
CH = CH 2 CH 3 -CH (CH 3 ) -CH 2 -Ph-C * H (CH 3 ) -CH 2 -Ph-OC 6 F 12 -OCO-CH
= CH 2 CH 3 -CH (CH 3 ) -CH 2 -Ph-C * H (CH 3 ) -CH 2 -Ph-COO-C 2 H 4 -OCO-C
(CH 3 ) = CH 2 CH 3 -CH (CH 3 ) -CH 2 -Ph-C * H (CH 3 ) -CH 2 -Ph-COO-C 4 H 8 -OCO-C
(CH 3 ) = CH 2 CH 3 -CH (CH 3 ) -CH 2 -Ph-C * H (CH 3 ) -CH 2 -Ph-COO-C 6 H 12 -OCO-
C (CH 3 ) = CH 2 CH 3 -CH (CH 3 ) -CH 2 -Ph-C * H (CH 3 ) -CH 2 -Ph-OC 6 H 12 -OCO-C
(CH 3 ) = CH 2 C 6 H 13 -O-Ph-C * H (CH 3 ) -CH 2 -Ph-COO-C 6 H 12 -OCO-CH = CH 2 C 6 H 13 -O-Ph -C * H (CH 3) -CH 2 -Ph-OC 6 H 12 -OCO-CH = CH 2 C 6 H 13 - C * H (CH 3) -O-Ph- C * H (CH 3) - CH 2 -Ph-COO-C 6 H 12 -
OCO-CH = CH 2 C 6 H 13 -C * H (CH 3 ) -O-Ph-C * H (CH 3 ) -CH 2 -Ph-OC 6 H 12 -OC
OC (CH 3 ) = CH 2 C 5 F 10 -CH 2 O-Ph- C * H (CH 3 ) -CH 2 -Ph-COO-C 6 H 12 -OCO-CH = C
H 2 C 5 F 10 -CH 2 O-Ph- C * H (CH 3) -CH 2 -Ph-OC 6 H 12 -OCO-CH = CH 2 CH 3 -O-Np-C * H (CH 3 ) -CH 2 -Ph-COO-C 6 H 12 -OCO-CH = CH 2 CH 3 -O-Np-C * H (CH 3 ) -CH 2 -Ph-OC 6 H 12 -OCO-CH = CH Two

【0023】環基を3個有する化合物としては、下記化
合物が好ましく挙げられる。 H-Ph-Ph- C* H(CH3)-CH2-Ph-COO-C6H12-OCO-CH=CH2 H-Ph-Ph- C* H(CH3)-CH2-Ph-O-C6H12-OCO-CH=CH2 H-Ph- PhF -C* H(CH3)-CH2-Ph-COO-C6H12-OCO-CH=CH2 H-Ph- PhF -C* H(CH3)-CH2-Ph-O-C6H12-OCO-CH=CH2 H-Ph- PhF -C* H(CH3)-CH2-Ph-COO-C6H12-OCO-C(CH3)=C
H2 H-Ph- PhF -C* H(CH3)-CH2-Ph-O-C6H12-OCO-C(CH3)=CH2 H-Ph-C* H(CH3)-CH2-Ph-Ph-COO-C2H4-OCO-CH=CH2 H-Ph-C* H(CH3)-CH2-Ph-Ph-COO-C4H8-OCO-CH=CH2 H-Ph-C* H(CH3)-CH2-Ph-Ph-COO-C6H12-OCO-CH=CH2 H-Ph-C* H(CH3)-CH2-Ph-Ph-O-C6H12-OCO-CH=CH2 H-Ph-C* H(CH3)-CH2-Ph-Ph-COO-C6H12-OCO-C(CH3)=CH2 H-Ph-C* H(CH3)-CH2-Ph-Ph-O-C6H12-OCO-C(CH3)=CH2 H-Ph-C* H(CH3)-CH2- PhF -Ph-COO-C6H12-OCO-CH=CH2 H-Ph-C* H(CH3)-CH2-Ph-PhF -O-C6H12-OCO-CH=CH2 H-Ph-C* H(CH3)-CH2- PhM -Ph-COO-C6H12-OCO-CH=CH2 H-Ph-C* H(CH3)-CH2-Ph-PhFF-O-C6H12-OCO-CH=CH2 H-Ph-C* H(CH3)-CH2-Ph-Ph-COO-C5H10-C5F10-OCO-CH=CH
2 H-Ph-C* H(CF3)-CH2-Ph-Ph-COO-C6F12-OCO-CH=CH2 H-Ph-C* H(CF3)-CH2-Ph-Ph-O-C6H12-OCO-C(CH3)=CH2 H-Ph-C* H(CH3)-CH2-Ph-COO-Ph-COO-C6H12-OCO-C(CH3)=
CH2 H-Ph-C* H(CH3)-CH2-Ph-COO-Ph-O-C6H12-OCO-CH=CH2 H-Ph-C* H(CH3)-CH2-Ph-OCO-Ph-O-C6H12-OCO-CH=CH2 H-Ph-C* H(CH3)-CH2-Ph-Cy-CH2O-C6H12-OCO-C(CH3)=CH2 H-Ph-C* H(CH3)-CH2-Ph-COO-Cy-COO-C6H12-OCO-CH=CH2 H-Ph-C* H(CH3)-CH2-Ph-CH2CH2-Ph-COO-C6H12-OCO-C(CH
3)=CH2 H-Ph-C* H(CH3)-CH2-Ph-CH2CH2-Ph-O-C6H12-OCO-CH=CH2 H-Ph-C* H(CH3)-CH2-Ph-CH2CH2-Cy-COO-C6H12-OCO-CH=C
H2 H-Ph-C* H(CH3)-CH2-Ph-CH2CH2-Cy-CH2O-C6H12-OCO-C(C
H3)=CH2 H-Ph-C* H(CH3)-CH2-Ph-CH2CH2-Cy-O-C6H12-OCO-C(CH3)
=CH2 CH3-CH(CH3)-CH2-Ph-C* H(CH3)-CH2-Ph-Ph-COO-C6H12-O
CO-CH=CH2 CH3-CH(CH3)-CH2-Ph-C* H(CH3)-CH2-Ph-Ph-O-C6H12-OCO
-CH=CH2 CH3-CH(CH3)-CH2-Ph-C* H(CH3)-CH2-Ph-OCO-Ph-O-C6H12
-OCO-CH=CH2 C6H13-O-Ph-C* H(CH3)-CH2-Ph-Ph-COO-C6H12-OCO-CH=CH
2 C6H13-O-Ph-C* H(CH3)-CH2-Ph-Ph-O-C6H12-OCO-CH=CH2 C6H13-O-Ph-C* H(CH3)-CH2-Ph-OCO-Ph-O-C6H12-OCO-CH=
CH2 CH3-O-Np-C* H(CH3)-CH2-Ph-Ph-COO-C6H12-OCO-CH=CH2 CH3-O-Np-C* H(CH3)-CH2-Ph-Ph-O-C6H12-OCO-CH=CH2 CH3-O-Np-C* H(CH3)-CH2-Ph-OCO-Ph-O-C6H12-OCO-CH=CH
2
Preferred examples of the compound having three ring groups include the following compounds. H-Ph-Ph- C * H (CH 3 ) -CH 2 -Ph-COO-C 6 H 12 -OCO-CH = CH 2 H-Ph-Ph- C * H (CH 3 ) -CH 2 -Ph -OC 6 H 12 -OCO-CH = CH 2 H-Ph- Ph F -C * H (CH 3 ) -CH 2 -Ph-COO-C 6 H 12 -OCO-CH = CH 2 H-Ph- Ph F -C * H (CH 3 ) -CH 2 -Ph-OC 6 H 12 -OCO-CH = CH 2 H-Ph- Ph F -C * H (CH 3 ) -CH 2 -Ph-COO-C 6 H 12 -OCO-C (CH 3 ) = C
H 2 H-Ph- Ph F -C * H (CH 3 ) -CH 2 -Ph-OC 6 H 12 -OCO-C (CH 3 ) = CH 2 H-Ph-C * H (CH 3 ) -CH 2 -Ph-Ph-COO-C 2 H 4 -OCO-CH = CH 2 H-Ph-C * H (CH 3 ) -CH 2 -Ph-Ph-COO-C 4 H 8 -OCO-CH = CH 2 H-Ph-C * H (CH 3 ) -CH 2 -Ph-Ph-COO-C 6 H 12 -OCO-CH = CH 2 H-Ph-C * H (CH 3 ) -CH 2 -Ph- Ph-OC 6 H 12 -OCO-CH = CH 2 H-Ph-C * H (CH 3 ) -CH 2 -Ph-Ph-COO-C 6 H 12 -OCO-C (CH 3 ) = CH 2 H -Ph-C * H (CH 3 ) -CH 2 -Ph-Ph-OC 6 H 12 -OCO-C (CH 3) = CH 2 H-Ph-C * H (CH 3) -CH 2 - Ph F -Ph-COO-C 6 H 12 -OCO-CH = CH 2 H-Ph-C * H (CH 3 ) -CH 2 -Ph-Ph F -OC 6 H 12 -OCO-CH = CH 2 H-Ph -C * H (CH 3) -CH 2 - Ph M -Ph-COO-C 6 H 12 -OCO-CH = CH 2 H-Ph-C * H (CH 3) -CH 2 -Ph-Ph FF - OC 6 H 12 -OCO-CH = CH 2 H-Ph-C * H (CH 3 ) -CH 2 -Ph-Ph-COO-C 5 H 10 -C 5 F 10 -OCO-CH = CH
2 H-Ph-C * H (CF 3 ) -CH 2 -Ph-Ph-COO-C 6 F 12 -OCO-CH = CH 2 H-Ph-C * H (CF 3 ) -CH 2 -Ph- Ph-OC 6 H 12 -OCO-C (CH 3 ) = CH 2 H-Ph-C * H (CH 3 ) -CH 2 -Ph-COO-Ph-COO-C 6 H 12 -OCO-C (CH 3 ) =
CH 2 H-Ph-C * H (CH 3) -CH 2 -Ph-COO-Ph-OC 6 H 12 -OCO-CH = CH 2 H-Ph-C * H (CH 3) -CH 2 -Ph -OCO-Ph-OC 6 H 12 -OCO-CH = CH 2 H-Ph-C * H (CH 3 ) -CH 2 -Ph-Cy-CH 2 OC 6 H 12 -OCO-C (CH 3 ) = CH 2 H-Ph-C * H (CH 3) -CH 2 -Ph-COO-Cy-COO-C 6 H 12 -OCO-CH = CH 2 H-Ph-C * H (CH 3) -CH 2 -Ph-CH 2 CH 2 -Ph-COO-C 6 H 12 -OCO-C (CH
3 ) = CH 2 H-Ph-C * H (CH 3 ) -CH 2 -Ph-CH 2 CH 2 -Ph-OC 6 H 12 -OCO-CH = CH 2 H-Ph-C * H (CH 3 ) -CH 2 -Ph-CH 2 CH 2 -Cy-COO-C 6 H 12 -OCO-CH = C
H 2 H-Ph-C * H (CH 3 ) -CH 2 -Ph-CH 2 CH 2 -Cy-CH 2 OC 6 H 12 -OCO-C (C
H 3 ) = CH 2 H-Ph-C * H (CH 3 ) -CH 2 -Ph-CH 2 CH 2 -Cy-OC 6 H 12 -OCO-C (CH 3 )
= CH 2 CH 3 -CH (CH 3 ) -CH 2 -Ph-C * H (CH 3 ) -CH 2 -Ph-Ph-COO-C 6 H 12 -O
CO-CH = CH 2 CH 3 -CH (CH 3 ) -CH 2 -Ph-C * H (CH 3 ) -CH 2 -Ph-Ph-OC 6 H 12 -OCO
-CH = CH 2 CH 3 -CH (CH 3 ) -CH 2 -Ph-C * H (CH 3 ) -CH 2 -Ph-OCO-Ph-OC 6 H 12
-OCO-CH = CH 2 C 6 H 13 -O-Ph-C * H (CH 3 ) -CH 2 -Ph-Ph-COO-C 6 H 12 -OCO-CH = CH
2 C 6 H 13 -O-Ph-C * H (CH 3 ) -CH 2 -Ph-Ph-OC 6 H 12 -OCO-CH = CH 2 C 6 H 13 -O-Ph-C * H (CH 3 ) -CH 2 -Ph-OCO-Ph-OC 6 H 12 -OCO-CH =
CH 2 CH 3 -O-Np-C * H (CH 3 ) -CH 2 -Ph-Ph-COO-C 6 H 12 -OCO-CH = CH 2 CH 3 -O-Np-C * H (CH 3 ) -CH 2 -Ph-Ph-OC 6 H 12 -OCO-CH = CH 2 CH 3 -O-Np-C * H (CH 3 ) -CH 2 -Ph-OCO-Ph-OC 6 H 12 -OCO -CH = CH
Two

【0024】環基を4個有する化合物としては、下記化
合物が好ましく挙げられる。 H-Ph- PhF -C* H(CH3)-CH2-Ph-Ph-COO-C6H12-OCO-CH=CH
2 H-Ph- PhF -C* H(CH3)-CH2-Ph-Ph-O-C6H12-OCO-CH=CH2 H-Ph- PhF -C* H(CH3)-CH2-Ph-Ph-COO-C6H12-OCO-C(C
H3)=CH2 H-Ph- PhF -C* H(CH3)-CH2-Ph-Ph-O-C6H12-OCO-C(CH3)=
CH2 H-Ph-C* H(CH3)-CH2-Ph-COO-Ph-Ph-COO-C6H12-OCO-CH=C
H2 H-Ph-C* H(CH3)-CH2-Ph-COO-Ph-Ph-O-C6H12-OCO-CH=CH2 H-Ph-C* H(CH3)-CH2-Ph-COO-Ph-Cy-COO-C6H12-OCO-CH=C
H2 H-Ph-C* H(CH3)-CH2-Ph-OCH2-Cy-Ph-O-C6H12-OCO-CH=CH
2 H-Ph-C* H(CH3)-CH2-Ph-Ph-COO-Ph-COO-C6H12-OCO-CH=C
H2 H-Ph-C* H(CH3)-CH2-Ph-Ph-OCO-Ph-O-C6H12-OCO-CH=CH2 H-Ph-C* H(CH3)-CH2-Ph-Cy-COO-Ph-COO-C6H12-OCO-CH=C
H2 H-Ph-C* H(CH3)-CH2-Ph-Cy-CH2O-Ph-O-C6H12-OCO-CH=CH
2 H-Ph-C* H(CH3)-CH2-Ph-Ph-CH2CH2-Cy-COO-C6H12-OCO-C
H=CH2 H-Ph-C* H(CH3)-CH2-Ph-Ph-CH2CH2-Cy-CH2O-C6H12-OCO-
C(CH3)=CH2 H-Ph-C* H(CH3)-CH2-Ph-Ph-CH2CH2-Cy-O-C6H12-OCO-CH=
CH2 H-Ph-C* H(CH3)-CH2-Ph-Cy-CH2CH2-Cy-COO-C6H12-OCO-C
H=CH2 H-Ph-C* H(CH3)-CH2-Ph-Cy-CH2CH2-Cy-CH2O-C6H12-OCO-
C(CH3)=CH2 H-Ph-C* H(CH3)-CH2-Ph-Cy-CH2CH2-Cy-O-C6H12-OCO-CH=
CH2 H-Ph-C* H(CH3)-CH2-Ph-CH2CH2-Ph-Cy-COO-C6H12-OCO-C
H=CH2 H-Ph-C* H(CH3)-CH2-Ph-CH2CH2-Ph-Cy-CH2O-C6H12-OCO-
C(CH3)=CH2 H-Ph-C* H(CH3)-CH2-Ph-CH2CH2-Ph-Cy-O-C6H12-OCO-CH=
CH2 H-Ph-C* H(CH3)-CH2-Ph-CH2CH2-Cy-Ph-COO-C6H12-OCO-C
H=CH2 H-Ph-C* H(CH3)-CH2-Ph-CH2CH2-Cy-Ph-CH2O-C6H12-OCO-
C(CH3)=CH2 H-Ph-C* H(CH3)-CH2-Ph-CH2CH2-Cy-Ph-O-C6H12-OCO-CH=
CH2
Preferred examples of the compound having four ring groups include the following compounds. H-Ph- Ph F -C * H (CH 3 ) -CH 2 -Ph-Ph-COO-C 6 H 12 -OCO-CH = CH
2 H-Ph- Ph F -C * H (CH 3 ) -CH 2 -Ph-Ph-OC 6 H 12 -OCO-CH = CH 2 H-Ph- Ph F -C * H (CH 3 ) -CH 2 -Ph-Ph-COO-C 6 H 12 -OCO-C (C
H 3 ) = CH 2 H-Ph- Ph F -C * H (CH 3 ) -CH 2 -Ph-Ph-OC 6 H 12 -OCO-C (CH 3 ) =
CH 2 H-Ph-C * H (CH 3 ) -CH 2 -Ph-COO-Ph-Ph-COO-C 6 H 12 -OCO-CH = C
H 2 H-Ph-C * H (CH 3 ) -CH 2 -Ph-COO-Ph-Ph-OC 6 H 12 -OCO-CH = CH 2 H-Ph-C * H (CH 3 ) -CH 2 -Ph-COO-Ph-Cy-COO-C 6 H 12 -OCO-CH = C
H 2 H-Ph-C * H (CH 3 ) -CH 2 -Ph-OCH 2 -Cy-Ph-OC 6 H 12 -OCO-CH = CH
2 H-Ph-C * H (CH 3 ) -CH 2 -Ph-Ph-COO-Ph-COO-C 6 H 12 -OCO-CH = C
H 2 H-Ph-C * H (CH 3 ) -CH 2 -Ph-Ph-OCO-Ph-OC 6 H 12 -OCO-CH = CH 2 H-Ph-C * H (CH 3 ) -CH 2 -Ph-Cy-COO-Ph-COO-C 6 H 12 -OCO-CH = C
H 2 H-Ph-C * H (CH 3 ) -CH 2 -Ph-Cy-CH 2 O-Ph-OC 6 H 12 -OCO-CH = CH
2 H-Ph-C * H (CH 3 ) -CH 2 -Ph-Ph-CH 2 CH 2 -Cy-COO-C 6 H 12 -OCO-C
H = CH 2 H-Ph-C * H (CH 3 ) -CH 2 -Ph-Ph-CH 2 CH 2 -Cy-CH 2 OC 6 H 12 -OCO-
C (CH 3 ) = CH 2 H-Ph-C * H (CH 3 ) -CH 2 -Ph-Ph-CH 2 CH 2 -Cy-OC 6 H 12 -OCO-CH =
CH 2 H-Ph-C * H (CH 3 ) -CH 2 -Ph-Cy-CH 2 CH 2 -Cy-COO-C 6 H 12 -OCO-C
H = CH 2 H-Ph-C * H (CH 3 ) -CH 2 -Ph-Cy-CH 2 CH 2 -Cy-CH 2 OC 6 H 12 -OCO-
C (CH 3 ) = CH 2 H-Ph-C * H (CH 3 ) -CH 2 -Ph-Cy-CH 2 CH 2 -Cy-OC 6 H 12 -OCO-CH =
CH 2 H-Ph-C * H (CH 3 ) -CH 2 -Ph-CH 2 CH 2 -Ph-Cy-COO-C 6 H 12 -OCO-C
H = CH 2 H-Ph-C * H (CH 3 ) -CH 2 -Ph-CH 2 CH 2 -Ph-Cy-CH 2 OC 6 H 12 -OCO-
C (CH 3 ) = CH 2 H-Ph-C * H (CH 3 ) -CH 2 -Ph-CH 2 CH 2 -Ph-Cy-OC 6 H 12 -OCO-CH =
CH 2 H-Ph-C * H (CH 3 ) -CH 2 -Ph-CH 2 CH 2 -Cy-Ph-COO-C 6 H 12 -OCO-C
H = CH 2 H-Ph-C * H (CH 3 ) -CH 2 -Ph-CH 2 CH 2 -Cy-Ph-CH 2 OC 6 H 12 -OCO-
C (CH 3 ) = CH 2 H-Ph-C * H (CH 3 ) -CH 2 -Ph-CH 2 CH 2 -Cy-Ph-OC 6 H 12 -OCO-CH =
CH 2

【0025】[式(3)が示す化合物の具体例]式
(3)が示す化合物としては、下記化合物が好ましく挙
げられる。 H-Ph-C* H(CH3)-CH2-Ph-COOH H-Ph-C* H(CH3)-CH2- PhF -COOH H-Ph-C* H(CH3)-CH2- PhFF-COOH H-Ph-C* H(CH3)-CH2- PhM -COOH H-Ph-C* H(CH3)-CH2-Ph-Ph-COOH H-Ph-C* H(CH3)-CH2-Ph-Cy-COOH H-Ph-C* H(CH3)-CH2- PhF -Ph-COOH H-Ph-C* H(CH3)-CH2-Ph-PhFF-COOH H-Ph-C* H(CH3)-CH2- PhM -Ph-COOH H-Ph-C* H(CF3)-CH2-Ph-COOH H-Ph-C* H(CF3)-CH2- PhF -COOH H-Ph-C* H(CF3)-CH2- PhFF-COOH H-Ph-C* H(CF3)-CH2- PhM -COOH H-Ph-C* H(CF3)-CH2-Ph-Ph-COOH H-Ph-C* H(CF3)-CH2- PhF -Ph-COOH H-Ph-C* H(CF3)-CH2-Ph-PhFF-COOH H-Ph-C* H(CF3)-CH2- PhM -Ph-COOH CH3-CH(CH3)-CH2-Ph-C* H(CH3)-CH2-Ph-COOH CH3-CH(CH3)-CH2-Ph-C* H(CH3)-CH2- PhF -COOH CH3-CH(CH3)-CH2-Ph-C* H(CH3)-CH2- PhFF-COOH CH3-CH(CH3)-CH2-Ph-C* H(CH3)-CH2- PhM -COOH CH3-CH(CH3)-CH2-Ph-C* H(CH3)-CH2-Ph-Ph-COOH CH3-CH(CH3)-CH2-Ph-C* H(CH3)-CH2- PhF -Ph-COOH CH3-CH(CH3)-CH2-Ph-C* H(CH3)-CH2-Ph-PhFF-COOH CH3-CH(CH3)-CH2-Ph-C* H(CH3)-CH2- PhM -Ph-COOH CH3-O-Ph-C* H(CH3)-CH2-Ph-COOH CH3-O-Ph-C* H(CH3)-CH2- PhF -COOH CH3-O-Ph-C* H(CH3)-CH2- PhFF-COOH CH3-O-Ph-C* H(CH3)-CH2- PhM -COOH CH3-O-Ph-C* H(CH3)-CH2-Ph-Ph-COOH CH3-O-Ph-C* H(CH3)-CH2- PhF -Ph-COOH CH3-O-Ph-C* H(CH3)-CH2-Ph-PhFF-COOH CH3-O-Ph-C* H(CH3)-CH2- PhM -Ph-COOH C6H13-O-Ph-C* H(CH3)-CH2-Ph-COOH C6H13-O-Ph-C* H(CH3)-CH2-Ph-Ph-COOH C6H13- C* H(CH3)-O-Ph- C* H(CH3)-CH2-Ph-COOH C6H13- C* H(CH3)-O-Ph- C* H(CH3)-CH2- PhF -COOH C6H13- C* H(CH3)-O-Ph- C* H(CH3)-CH2- PhFF-COOH C6H13- C* H(CH3)-O-Ph- C* H(CH3)-CH2- PhM -COOH C6H13- C* H(CH3)-O-Ph- C* H(CH3)-CH2-Ph-Ph-COOH C6H13- C* H(CH3)-O-Ph- C* H(CH3)-CH2- PhF -Ph-COOH C6H13- C* H(CH3)-O-Ph- C* H(CH3)-CH2-Ph-PhFF-COOH C6H13- C* H(CH3)-O-Ph- C* H(CH3)-CH2- PhM -Ph-COOH C5F10- CH2O-Ph-C* H(CH3)-CH2-Ph-COOH H-Ph- Ph-C* H(CH3)-CH2-Ph-COOH H-Ph- PhF -C* H(CH3)-CH2-Ph-COOH H-Ph- PhF -C* H(CH3)-CH2- PhF -COOH H-Ph- PhF -C* H(CH3)-CH2- PhFF-COOH H-Ph- PhF -C* H(CH3)-CH2- PhM -COOH H-Ph- PhF -C* H(CH3)-CH2-Ph-Ph-COOH H-Ph- PhF -C* H(CH3)-CH2- PhF -Ph-COOH H-Ph- PhF -C* H(CH3)-CH2-Ph-PhFF-COOH H-Ph- PhF -C* H(CH3)-CH2- PhM -Ph-COOH CH3-O-Np-C* H(CH3)-CH2-Ph-COOHCH3-O-Np-C* H(CH3)-C
H2- PhF -COOH CH3-O-Np-C* H(CH3)-CH2- PhFF-COOH CH3-O-Np-C* H(CH3)-CH2- PhM -COOH CH3-O-Np-C* H(CH3)-CH2-Ph-Ph-COOH CH3-O-Np-C* H(CH3)-CH2- PhF -Ph-COOH CH3-O-Np-C* H(CH3)-CH2-Ph-PhFF-COOH CH3-O-Np-C* H(CH3)-CH2- PhM -Ph-COOH
[Specific examples of the compound represented by the formula (3)] As the compound represented by the formula (3), the following compounds are preferably exemplified. H-Ph-C * H ( CH 3) -CH 2 -Ph-COOH H-Ph-C * H (CH 3) -CH 2 - Ph F -COOH H-Ph-C * H (CH 3) -CH 2 -Ph FF -COOH H-Ph-C * H (CH 3 ) -CH 2 -Ph M -COOH H-Ph-C * H (CH 3 ) -CH 2 -Ph-Ph-COOH H-Ph-C * H (CH 3 ) -CH 2 -Ph-Cy-COOH H-Ph-C * H (CH 3 ) -CH 2 -Ph F -Ph-COOH H-Ph-C * H (CH 3 ) -CH 2 -Ph-Ph FF -COOH H-Ph-C * H (CH 3 ) -CH 2 -Ph M -Ph-COOH H-Ph-C * H (CF 3 ) -CH 2 -Ph-COOH H-Ph- C * H (CF 3 ) -CH 2 -Ph F -COOH H-Ph-C * H (CF 3 ) -CH 2 -Ph FF -COOH H-Ph-C * H (CF 3 ) -CH 2 -Ph M -COOH H-Ph-C * H (CF 3 ) -CH 2 -Ph-Ph-COOH H-Ph-C * H (CF 3 ) -CH 2 -Ph F -Ph-COOH H-Ph-C * H (CF 3 ) -CH 2 -Ph-Ph FF -COOH H-Ph-C * H (CF 3 ) -CH 2 -Ph M -Ph-COOH CH 3 -CH (CH 3 ) -CH 2 -Ph- C * H (CH 3) -CH 2 -Ph-COOH CH 3 -CH (CH 3) -CH 2 -Ph-C * H (CH 3) -CH 2 - Ph F -COOH CH 3 -CH (CH 3 ) -CH 2 -Ph-C * H (CH 3) -CH 2 - Ph FF -COOH CH 3 -CH (CH 3) -CH 2 -Ph-C * H (CH 3) -CH 2 - Ph M - COOH CH 3 -CH (CH 3 ) -CH 2 -Ph-C * H (CH 3 ) -CH 2 -Ph-Ph-COOH CH 3 -CH (CH 3 ) -CH 2 -Ph-C * H (CH 3 ) -CH 2 -Ph F -Ph-COOH CH 3 -CH (CH 3 ) -CH 2 -Ph-C * H (CH 3 ) -CH 2- Ph-Ph FF -COOH CH 3 -CH (CH 3 ) -CH 2 -Ph-C * H (CH 3 ) -CH 2 -Ph M -Ph-COOH CH 3 -O-Ph-C * H (CH 3 ) -CH 2 -Ph-COOH CH 3 -O-Ph-C * H (CH 3 ) -CH 2 -Ph F -COOH CH 3 -O-Ph-C * H (CH 3 ) -CH 2 -Ph FF -COOH CH 3 -O-Ph-C * H (CH 3 ) -CH 2 -Ph M -COOH CH 3 -O-Ph-C * H (CH 3 ) -CH 2 -Ph-Ph-COOH CH 3- O-Ph-C * H (CH 3 ) -CH 2 -Ph F -Ph-COOH CH 3 -O-Ph-C * H (CH 3 ) -CH 2 -Ph-Ph FF -COOH CH 3 -O- Ph-C * H (CH 3 ) -CH 2 -Ph M -Ph-COOH C 6 H 13 -O-Ph-C * H (CH 3 ) -CH 2 -Ph-COOH C 6 H 13 -O-Ph -C * H (CH 3) -CH 2 -Ph-Ph-COOH C 6 H 13 - C * H (CH 3) -O-Ph- C * H (CH 3) -CH 2 -Ph-COOH C 6 H 13 - C * H (CH 3) -O-Ph- C * H (CH 3) -CH 2 - Ph F -COOH C 6 H 13 - C * H (CH 3) -O-Ph- C * H (CH 3 ) -CH 2 -Ph FF -COOH C 6 H 13 -C * H (CH 3 ) -O-Ph-C * H (CH 3 ) -CH 2 -Ph M -COOH C 6 H 13 -C * H (CH 3 ) -O-Ph- C * H (CH 3 ) -CH 2 -Ph-Ph-COOH C 6 H 13 -C * H (CH 3 ) -O-Ph- C * H (CH 3 ) -CH 2 - Ph F -Ph- COOH C 6 H 13 - C * H (CH 3) -O-Ph- C * H (CH 3) -CH 2 -Ph-Ph FF -COOH C 6 H 13 - C * H (CH 3) -O -Ph- C * H (CH 3) -CH 2 - Ph M -Ph-COOH C 5 F 10 -CH 2 O-Ph-C * H (CH 3 ) -CH 2 -Ph-COOH H-Ph- Ph-C * H (CH 3 ) -CH 2 -Ph-COOH H-Ph- Ph F -C * H (CH 3 ) -CH 2 -Ph-COOH H-Ph- Ph F -C * H (CH 3 ) -CH 2 -Ph F -COOH H-Ph- Ph F -C * H (CH 3 )- CH 2 -Ph FF -COOH H-Ph- Ph F -C * H (CH 3 ) -CH 2 -Ph M -COOH H-Ph- Ph F -C * H (CH 3 ) -CH 2 -Ph-Ph -COOH H-Ph- Ph F -C * H (CH 3 ) -CH 2 -Ph F -Ph-COOH H-Ph- Ph F -C * H (CH 3 ) -CH 2 -Ph-Ph FF -COOH H-Ph- Ph F -C * H (CH 3 ) -CH 2 -Ph M -Ph-COOH CH 3 -O-Np-C * H (CH 3 ) -CH 2 -Ph-COOHCH 3 -O-Np -C * H (CH 3) -C
H 2 -Ph F -COOH CH 3 -O-Np-C * H (CH 3 ) -CH 2 -Ph FF -COOH CH 3 -O-Np-C * H (CH 3 ) -CH 2 -Ph M- COOH CH 3 -O-Np-C * H (CH 3 ) -CH 2 -Ph-Ph-COOH CH 3 -O-Np-C * H (CH 3 ) -CH 2 -Ph F -Ph-COOH CH 3 -O-Np-C * H (CH 3 ) -CH 2 -Ph-Ph FF -COOH CH 3 -O-Np-C * H (CH 3 ) -CH 2 -Ph M -Ph-COOH

【0026】[製造方法の説明]化合物(3)または
(2)の製造方法を以下に示す。下記の製造方法は単な
る例示であり、反応温度、反応溶媒、還元剤および触媒
等は、必要に応じて変更してもよい。また、それぞれの
反応において、式中の光学活性化合物の立体配置は保持
される。
[Description of Production Method] The production method of the compound (3) or (2) is shown below. The following production method is merely an example, and the reaction temperature, reaction solvent, reducing agent, catalyst, and the like may be changed as necessary. In each reaction, the configuration of the optically active compound in the formula is maintained.

【0027】[化合物(3)の製造方法の説明]はじめ
に、式(4)で表されるカルボン酸を塩素化し、式(1
0)で表される酸クロライドとする。塩素化剤は塩化チ
オニルまたは塩化オキサリルが好ましい。反応は無溶媒
でも溶媒を使用してもよいが、作業性等からテトラクロ
ロエチレン、ジクロロメタン、ジクロロエタン等の溶媒
を用いることが好ましい。反応温度は50℃以下が好ま
しい。 R-X1-A1-B1-C* HY1-COOH …式(4) R-X1-A1-B1-C* HY1-COCl …式(10)
[Explanation of Method for Producing Compound (3)] First, the carboxylic acid represented by the formula (4) is chlorinated to give a compound represented by the formula (1)
0). The chlorinating agent is preferably thionyl chloride or oxalyl chloride. The reaction may be carried out without solvent or with a solvent, but it is preferable to use a solvent such as tetrachloroethylene, dichloromethane, dichloroethane or the like from the viewpoint of workability. The reaction temperature is preferably 50 ° C or lower. RX 1 -A 1 -B 1 -C * HY 1 -COOH ... Equation (4) RX 1 -A 1 -B 1 -C * HY 1 -COCl ... Equation (10)

【0028】得られた式(10)で表される酸クロライ
ドを、式(5)で表されるグリニャール試薬とカップリ
ング反応させる。式(5)におけるQ’は臭素原子また
はヨウ素原子であるが、反応性、コストの点から臭素原
子が好ましい。Qはハロゲン原子であるが、Q’が臭素
原子の場合はQはヨウ素原子ではない。式(5)で表さ
れるグリニャール試薬は、下式(11)で表されるハロ
ゲン化物と金属マグネシウムから常法により容易に調製
できる。この反応においては、収率の向上、副反応の抑
制効果から有機金属錯体を触媒として用いることが好ま
しい。有機金属錯体としては、鉄(III)−アセチルアセ
トナート、ニッケル(II)−アセチルアセトナート、コ
バルト(II)−アセチルアセトナート、銅(II)−アセ
チルアセトナート、ジクロロ(1,2−ビス(ジフェニ
ルホスフィノ)エタン)ニッケル、テトラキス(トリフ
ェニルホスフィン)パラジウム(0)等が好ましく挙げ
られる。反応溶媒は、作業性等の観点から、テトラヒド
ロフランが好ましい。また、式(5)で表されるグリニ
ャール試薬は、水により容易に分解するので、反応溶媒
は金属ナトリウムなどで完全に脱水してから使用するの
が好ましい。反応温度は−10〜30℃が好ましい。以
上の反応により式(6)で表されるケトンが得られる。 Q'-Mg-(B2)n -Q …式(5) Q'-(B2) n -Q …式(11) R-X1-A1-B1-C* HY1-CO- (B2)n -Q …式(6)
The obtained acid chloride represented by the formula (10) is subjected to a coupling reaction with a Grignard reagent represented by the formula (5). Q ′ in the formula (5) is a bromine atom or an iodine atom, and is preferably a bromine atom in terms of reactivity and cost. Q is a halogen atom, but when Q ′ is a bromine atom, Q is not an iodine atom. The Grignard reagent represented by the formula (5) can be easily prepared from a halide represented by the following formula (11) and magnesium metal by a conventional method. In this reaction, it is preferable to use an organometallic complex as a catalyst from the viewpoint of improving the yield and suppressing side reactions. Examples of the organometallic complex include iron (III) -acetylacetonate, nickel (II) -acetylacetonate, cobalt (II) -acetylacetonate, copper (II) -acetylacetonate, and dichloro (1,2-bis ( Preferred examples include diphenylphosphino) ethane) nickel and tetrakis (triphenylphosphine) palladium (0). The reaction solvent is preferably tetrahydrofuran from the viewpoint of workability and the like. Since the Grignard reagent represented by the formula (5) is easily decomposed by water, it is preferable to use the reaction solvent after completely dehydrating it with metallic sodium or the like. The reaction temperature is preferably from -10 to 30C. By the above reaction, a ketone represented by the formula (6) is obtained. Q'-Mg- (B 2 ) n -Q ... Equation (5) Q '-(B 2 ) n -Q ... Equation (11) RX 1 -A 1 -B 1 -C * HY 1 -CO- (B 2 ) n -Q… Equation (6)

【0029】化合物(6)であるケトンを還元すること
により、化合物(7)が得られる。本反応における還元
剤は特に限定されないが、作業性等から、塩化アルミニ
ウム存在下の水素化リチウムアルミニウム、トリフルオ
ロ酢酸存在下のトリエチルシランまたは塩化アルミニウ
ム存在下のトリエチルシラン等が好ましい。反応は無溶
媒でも溶媒を使用しても可能であるが、作業性、安全性
の観点からテトラヒドロフラン、ジエチルエーテル、メ
チル−t−ブチルエーテル等を用いるのが好ましい。反
応温度は0〜30℃が好ましい。 R-X1-A1-B1-C* HY1-CH2-(B2)n -Q …式(7)
The compound (7) is obtained by reducing the ketone as the compound (6). The reducing agent in this reaction is not particularly limited, but lithium aluminum hydride in the presence of aluminum chloride, triethylsilane in the presence of trifluoroacetic acid, triethylsilane in the presence of aluminum chloride, and the like are preferable from the viewpoint of workability and the like. The reaction can be carried out without a solvent or using a solvent, but from the viewpoint of workability and safety, it is preferable to use tetrahydrofuran, diethyl ether, methyl-t-butyl ether, or the like. The reaction temperature is preferably from 0 to 30C. RX 1 -A 1 -B 1 -C * HY 1 -CH 2- (B 2 ) n -Q ... Equation (7)

【0030】さらに、化合物(7)から式(8)で表さ
れるグリニャール試薬を調製し、式(8)で表されるグ
リニャール試薬を二酸化炭素と反応させた後に、酸によ
り加水分解することにより、カルボン酸である本発明の
化合物(3)が得られる。式(8)で表されるグリニャ
ール試薬は、化合物(7)と金属マグネシウムまたはエ
チルマグネシウムブロミドから常法により容易に調製で
きる。作業性、安全性等からエチルマグネシウムブロミ
ドを用いることが好ましく、反応溶媒はテトラヒドロフ
ランが好ましい。また、前述のようにグリニャール試薬
は、水により容易に分解するので、反応溶媒は金属ナト
リウムなどで完全に脱水してから使用するのが好まし
い。二酸化炭素は気体、固体(ドライアイス)のどちら
を用いてもよいが、作業性、安全性等から気体を用いる
ことが好ましい。反応温度は−30〜20℃が好まし
い。加水分解に用いる酸は希塩酸が好ましい。 R-X1-A1-B1-C* HY1-CH2-(B2)n -Mg-Q …式(8) R-X1-A1-B1-C* HY1-CH2-(B2)n -COOH …式(3)
Further, a Grignard reagent represented by the formula (8) is prepared from the compound (7), and the Grignard reagent represented by the formula (8) is reacted with carbon dioxide, followed by hydrolysis with an acid. And the compound (3) of the present invention, which is a carboxylic acid, is obtained. The Grignard reagent represented by the formula (8) can be easily prepared from the compound (7) and magnesium metal or ethylmagnesium bromide by an ordinary method. It is preferable to use ethyl magnesium bromide from the viewpoints of workability and safety, and the reaction solvent is preferably tetrahydrofuran. Since the Grignard reagent is easily decomposed by water as described above, it is preferable to use the reaction solvent after completely dehydrating it with metallic sodium or the like. As carbon dioxide, either gas or solid (dry ice) may be used, but it is preferable to use gas from the viewpoint of workability and safety. The reaction temperature is preferably -30 to 20C. The acid used for the hydrolysis is preferably dilute hydrochloric acid. RX 1 -A 1 -B 1 -C * HY 1 -CH 2- (B 2 ) n -Mg-Q… Equation (8) RX 1 -A 1 -B 1 -C * HY 1 -CH 2- (B 2 ) n -COOH… Equation (3)

【0031】[化合物(2)の製造方法の説明]本発明
の化合物(2)は、その中間体となる光学活性化合物
(3)から製造できる。まず、化合物(3)を塩化チオ
ニルにて塩素化し、式(12)で表される酸クロライド
を得る。反応溶媒はテトラクロロエチレンが好ましい。
反応温度は50℃以下が好ましい。また、塩化チオニル
の代わりに塩化オキサリルを用いてもよい。次いで、ピ
リジンの存在下、式(12)で表される酸クロライドを
式(9)で表されるアルコールと反応させることによ
り、本発明の化合物(2)が得られる。反応溶媒はジク
ロロメタンまたはトルエンが好ましい。また、ピリジン
の代わりにトリエチルアミンを用いてもよい。反応温度
は40℃以下が好ましい。 R-X1-A1-B1-C* HY1-CH2-(B2)n -COCl …式(12) HO-A2-X3-A3-X4-Z-OCO-CY2=CH2 …式(9) R-X1-A1-B1-C* HY1-CH2-(B2)n -COO-A2-X3-A3-X4-Z-OCO-CY2=CH2…式(2)
[Explanation of Production Method of Compound (2)] The compound (2) of the present invention can be produced from an optically active compound (3) which is an intermediate thereof. First, the compound (3) is chlorinated with thionyl chloride to obtain an acid chloride represented by the formula (12). The reaction solvent is preferably tetrachloroethylene.
The reaction temperature is preferably 50 ° C or lower. Oxalyl chloride may be used instead of thionyl chloride. Next, the compound (2) of the present invention is obtained by reacting the acid chloride represented by the formula (12) with the alcohol represented by the formula (9) in the presence of pyridine. The reaction solvent is preferably dichloromethane or toluene. Further, triethylamine may be used instead of pyridine. The reaction temperature is preferably 40 ° C. or lower. RX 1 -A 1 -B 1 -C * HY 1 -CH 2- (B 2 ) n -COCl… Equation (12) HO-A 2 -X 3 -A 3 -X 4 -Z-OCO-CY 2 = CH 2 … Equation (9) RX 1 -A 1 -B 1 -C * HY 1 -CH 2- (B 2 ) n -COO-A 2 -X 3 -A 3 -X 4 -Z-OCO-CY 2 = CH 2 … Equation (2)

【0032】[化合物(1)の製造方法の説明]式
(1)で表される化合物のうち、例えば、X2 がエーテ
ル性の酸素原子(−O−)、A2 、A3 、X3 およびX
4 が単結合の場合は、次の方法で製造できる。
[Explanation of Method for Producing Compound (1)] Among the compounds represented by the formula (1), for example, X 2 is an etheric oxygen atom (—O—), A 2 , A 3 , X 3 And X
When 4 is a single bond, it can be produced by the following method.

【0033】[0033]

【化2】 Embedded image

【0034】はじめに、光学活性フェノール(a)に、
炭酸カリウムの存在下、テトラヒドロピラニル基(TH
P)で保護した水酸基を持つハロゲン化合物(b)を反
応させて化合物(c)を得る。反応溶媒はアセトン、シ
クロヘキサノンまたはメチルイソブチルケトン等が好ま
しい。反応温度は80〜150℃が好ましい。また、テ
トラヒドロピラニル基の代わりにメトキシメチル基で水
酸基を保護した化合物を用いてもよい。次いで、酸触媒
の存在下、化合物(c)の水酸基の脱保護を行い、アル
コール(d)を得る。酸触媒は、塩酸、p−トルエンス
ルホン酸、p−トルエンスルホン酸ピリジニウムまたは
酸性イオン交換樹脂等が好ましく、反応溶媒はメタノー
ル、テトラヒドロフランまたは水等が好ましい。反応温
度は100℃以下が好ましい。得られたアルコール
(d)に、酸触媒の存在下、アクリル酸(e(Y=
H))またはメタクリル酸(e(Y=CH3 ))を作用
させ、エステル化し、目的の化合物(1−1)を得るこ
とができる。反応溶媒はジクロロメタン、ジクロロエタ
ン、クロロホルムまたはトルエン等が好ましい。エステ
ル化は、DCC、DMAP等の脱水縮合体、またはp−
トルエンスルホン酸等の酸触媒を用いることが好まし
く、加熱還流下で反応させることが好ましい。この際、
ヒドロキノン、トリt−ブチルフェノール等の重合禁止
剤を添加することが好ましい。
First, the optically active phenol (a)
In the presence of potassium carbonate, a tetrahydropyranyl group (TH
The compound (c) is obtained by reacting the halogen compound (b) having a hydroxyl group protected by P). The reaction solvent is preferably acetone, cyclohexanone or methyl isobutyl ketone. The reaction temperature is preferably from 80 to 150 ° C. Further, a compound in which a hydroxyl group is protected by a methoxymethyl group instead of a tetrahydropyranyl group may be used. Next, the hydroxyl group of compound (c) is deprotected in the presence of an acid catalyst to obtain alcohol (d). The acid catalyst is preferably hydrochloric acid, p-toluenesulfonic acid, pyridinium p-toluenesulfonate or an acidic ion exchange resin, and the reaction solvent is preferably methanol, tetrahydrofuran or water. The reaction temperature is preferably 100 ° C. or lower. The obtained alcohol (d) was added to acrylic acid (e (Y =
H)) or methacrylic acid (e (Y = CH 3 )) to cause esterification to obtain the desired compound (1-1). The reaction solvent is preferably dichloromethane, dichloroethane, chloroform or toluene. Esterification is performed by dehydration condensate such as DCC or DMAP, or p-
It is preferable to use an acid catalyst such as toluenesulfonic acid, and it is preferable to carry out the reaction under heating and reflux. On this occasion,
It is preferable to add a polymerization inhibitor such as hydroquinone and tri-t-butylphenol.

【0035】化合物(1)は、その少なくとも1種を他
の重合可能な化合物、重合性官能基をもたない液晶材
料、または重合性官能基をもたない非液晶材料(以下、
これらを総称して「他の材料」と記す。)に含ませて液
晶組成物とする。他の材料中に化合物(1)を含ませ
て、共重合可能な液晶組成物とする場合には、式(1)
で表される化合物の合量は、共重合可能な液晶組成物中
に0.1〜80質量%含むのが好ましい。より好ましく
は、1〜70質量%、さらに好ましくは5〜60質量
%、特に好ましくは10〜50質量%である。また、該
液晶組成物中には式(1)で表される化合物を多成分含
んでいることが好ましく、この場合一成分の化合物につ
いては、該液晶組成物中に1〜10質量%含むのが好ま
しい。多成分含むことにより組成物の相溶性が良好とな
り、使用温度範囲が広がる。
The compound (1) is composed of at least one compound of another polymerizable compound, a liquid crystal material having no polymerizable functional group, or a non-liquid crystal material having no polymerizable functional group (hereinafter, referred to as a compound having no polymerizable functional group).
These are collectively referred to as "other materials". ) To form a liquid crystal composition. When compound (1) is contained in another material to form a copolymerizable liquid crystal composition, formula (1)
The total amount of the compound represented by the formula (1) is preferably 0.1 to 80% by mass in the copolymerizable liquid crystal composition. More preferably, it is 1 to 70% by mass, further preferably 5 to 60% by mass, particularly preferably 10 to 50% by mass. Further, it is preferable that the liquid crystal composition contains a compound represented by the formula (1) in multiple components. In this case, the compound of one component contains 1 to 10% by mass in the liquid crystal composition. Is preferred. By including multiple components, the compatibility of the composition becomes good and the working temperature range is widened.

【0036】他の重合可能な化合物としては、液晶性モ
ノマでも液晶性を示さないモノマでも使用できるが、相
溶性の観点から液晶性モノマが好ましい。
As the other polymerizable compound, a liquid crystal monomer or a monomer having no liquid crystal property can be used, but a liquid crystal monomer is preferable from the viewpoint of compatibility.

【0037】他の重合可能な化合物としては特に限定さ
れないが、下記の式で示される化合物が好ましく挙げら
れる。ただし、下式中mは1〜12、R’はアルキル基
を示す。 CH2=CHCOO(CH2)m O-Ph-COO-Ph-OCO-Ph- O(CH2)m -OCOCH
=CH2 CH2=CHCOO(CH2)m O-Ph-COO- PhM -OCO-Ph-O(CH2)m -OCO
CH=CH2 CH2=CHCOO(CH2)m O-Ph-Ph-O(CH2)m -OCOCH=CH2 CH2=CHCOO(CH2)m O-Ph-Ph-CN CH2=CHCOO-Ph-OCO-Ph-R' CH2=CHCOO-Ph-COO-Ph-OCO-Ph-OCOCH=CH2 CH2=CHCOO-Ph-COO- PhM -OCO-Ph-OCOCH=CH2 CH2=CHCOO-Ph-Ph-O(CH2)m -OCOCH=CH2 CH2=CHCOO-Ph-Ph-CN
The other polymerizable compound is not particularly limited, but is preferably a compound represented by the following formula. However, in the following formula, m represents 1 to 12, and R ′ represents an alkyl group. CH 2 = CHCOO (CH 2 ) m O-Ph-COO-Ph-OCO-Ph- O (CH 2 ) m -OCOCH
= CH 2 CH 2 = CHCOO (CH 2 ) m O-Ph-COO- Ph M -OCO-Ph-O (CH 2 ) m -OCO
CH = CH 2 CH 2 = CHCOO (CH 2 ) m O-Ph-Ph-O (CH 2 ) m -OCOCH = CH 2 CH 2 = CHCOO (CH 2 ) m O-Ph-Ph-CN CH 2 = CHCOO -Ph-OCO-Ph-R 'CH 2 = CHCOO-Ph-COO-Ph-OCO-Ph-OCOCH = CH 2 CH 2 = CHCOO-Ph-COO- Ph M -OCO-Ph-OCOCH = CH 2 CH 2 = CHCOO-Ph-Ph-O (CH 2 ) m -OCOCH = CH 2 CH 2 = CHCOO-Ph-Ph-CN

【0038】具体的には下式で示される化合物が好まし
く挙げられる。 CH2=CHCOO(CH2)6O-Ph-COO-Ph-OCO-Ph-O(CH2)6-OCOCH=CH
2 CH2=CHCOO(CH2)11O-Ph-COO- PhM -OCO-Ph-O(CH2)11-OCO
CH=CH2 CH2=CHCOO(CH2)6O-Ph-Ph-O(CH2)6-OCOCH=CH2 CH2=CHCOO(CH2)3O-Ph-Ph-CN CH2=CHCOO(CH2)6O-Ph-Ph-CN CH2=CHCOO-Ph-OCO-Ph-C5H11 CH2=CHCOO-Ph-OCO-Ph-C4H9 CH2=CHCOO-Ph-Ph-CN これらは、1種でも2種以上を混合して用いることもで
きる。
Specifically, a compound represented by the following formula is preferably mentioned. CH 2 = CHCOO (CH 2 ) 6 O-Ph-COO-Ph-OCO-Ph-O (CH 2 ) 6 -OCOCH = CH
2 CH 2 = CHCOO (CH 2 ) 11 O-Ph-COO- Ph M -OCO-Ph-O (CH 2 ) 11 -OCO
CH = CH 2 CH 2 = CHCOO (CH 2 ) 6 O-Ph-Ph-O (CH 2 ) 6 -OCOCH = CH 2 CH 2 = CHCOO (CH 2 ) 3 O-Ph-Ph-CN CH 2 = CHCOO (CH 2 ) 6 O-Ph-Ph-CN CH 2 = CHCOO-Ph-OCO-Ph-C 5 H 11 CH 2 = CHCOO-Ph-OCO-Ph-C 4 H 9 CH 2 = CHCOO-Ph-Ph -CN These can be used alone or in combination of two or more.

【0039】また、重合性官能基をもたない液晶材料と
しては、公知の液晶材料であれば特に限定されず、ビフ
ェニル系、トラン系、ピリミジン系、シクロヘキサン
系、ジフロロスチルベン系などが挙げられ、用途、要求
性能等により適宜選択される。これらは1種でも2種以
上を混合して用いることもできる。重合性官能基をもた
ない液晶材料としては、例えば、下記の化合物が挙げら
れる。ただし、R1 およびR2 は相互に独立して、アル
キル基、アルケニル基、アルコキシ基、ハロゲン原子ま
たはシアノ基を示し、R1 およびR2 中の水素原子の1
個以上がハロゲン原子またはシアノ基等に置換されてい
てもよい。Z1 、Z 2 、Z3 、Z4 は、相互に独立し
て、五員環または六員環(例えば、シクロヘキサン環、
ベンゼン環、ジオキサン環、ピリミジン環またはピリジ
ン環等)の環構造を示し、非置換でも置換されていても
よい。また、環と環との間の結合基が他の結合基であっ
てもよい。他の結合基としては、−CH2 O−、−CH
=CH−、−N=N−、−CH=N−、−COOCH2
−、−OCOCH2 −、−COCH2 −等が挙げられ
る。
In addition, a liquid crystal material having no polymerizable functional group
There is no particular limitation as long as it is a known liquid crystal material.
Phenyl, tolan, pyrimidine, cyclohexane
System, difluorostilbene system, etc.
It is appropriately selected depending on performance and the like. One or more of these
The above can be mixed and used. Has a polymerizable functional group
Examples of non-liquid crystal materials include the following compounds.
It is. Where R1And RTwoAre independent of each other
Kill group, alkenyl group, alkoxy group, halogen atom
Or a cyano group;1And RTwoOne of the hydrogen atoms in the
Or more are substituted by halogen atoms or cyano groups, etc.
You may. Z1, Z Two, ZThree, ZFourAre independent of each other
And a five-membered or six-membered ring (eg, a cyclohexane ring,
Benzene ring, dioxane ring, pyrimidine ring or pyridi
Ring structure), unsubstituted or substituted
Good. Further, the bonding group between the rings is another bonding group.
You may. Other linking groups include -CHTwoO-, -CH
= CH-, -N = N-, -CH = N-, -COOCHTwo
-, -OCOCHTwo-, -COCHTwo-Etc.
You.

【0040】これらは、1種でも2種以上を混合して用
いることもでき、所望の性能に合わせて適宜選択され
る。なお、下記化合物は単なる例示であり、下記以外の
化合物を採用してもよい。 R1-Z1-Z2-R2 、R1-Z1-COO-Z2-R2 、R1-Z1-C ≡C-Z2-
R2 、R1-Z1-CH2CH2-Z2-R2、R1-Z1-CF=CF-Z2-R2 、R1-Z1
-Z2-Z3-R2、R1-Z1-COO-Z2-Z3-R2、R1-Z1-CH2CH2-Z2-Z3-
R2 、R1-Z1-CF=CF-Z2-Z3-R2、R1-Z1-C ≡C-Z2-Z3-R2、R
1-Z1-COO-Z2-COO-Z3-R2、R1-Z1-CH2CH2-Z2-COO-Z3-
R2 、R1-Z1-CH2CH2-Z2-C ≡C-Z3-R2 、R1-Z1-Z2-Z 3-Z4-
R2 、R1-Z1-CH2CH2-Z2-C ≡C-Z3-Z4-R2
These may be used alone or in combination of two or more.
Can be selected as appropriate for the desired performance.
You. In addition, the following compounds are only examples,
Compounds may be employed. R1-Z1-ZTwo-RTwo, R1-Z1-COO-ZTwo-RTwo, R1-Z1-C ≡C-ZTwo-
RTwo, R1-Z1-CHTwoCHTwo-ZTwo-RTwo, R1-Z1-CF = CF-ZTwo-RTwo, R1-Z1
-ZTwo-ZThree-RTwo, R1-Z1-COO-ZTwo-ZThree-RTwo, R1-Z1-CHTwoCHTwo-ZTwo-ZThree-
RTwo, R1-Z1-CF = CF-ZTwo-ZThree-RTwo, R1-Z1-C ≡C-ZTwo-ZThree-RTwo, R
1-Z1-COO-ZTwo-COO-ZThree-RTwo, R1-Z1-CHTwoCHTwo-ZTwo-COO-ZThree-
RTwo, R1-Z1-CHTwoCHTwo-ZTwo-C ≡C-ZThree-RTwo, R1-Z1-ZTwo-Z Three-ZFour-
RTwo, R1-Z1-CHTwoCHTwo-ZTwo-C ≡C-ZThree-ZFour-RTwo.

【0041】重合性官能基をもたない非液晶材料として
は、例えば、液晶組成物の保存安定性を保持するための
安定剤や、色素などが挙げられる。安定剤としては、ヒ
ドロキノン、ヒドロキノンモノアルキルエーテル類また
は第三ブチルカテコール類などが挙げられる。色素とし
ては、通常色素または2色性色素などが挙げられる。
Examples of the non-liquid crystal material having no polymerizable functional group include a stabilizer for maintaining the storage stability of the liquid crystal composition, and a dye. Examples of the stabilizer include hydroquinone, hydroquinone monoalkyl ethers and tert-butyl catechol. Examples of the dye include a normal dye and a dichroic dye.

【0042】化合物(1)を含む液晶組成物を共重合さ
せる場合には、適切な光重合開始剤を用いて、UV光に
よる照射によって行うことが好ましい。この際、支持体
としてガラス、プラスチック等を使用することができ
る。支持体面には必要に応じて配向処理を施してもよ
い。配向処理は、支持体面を綿、羊毛等の天然繊維、ナ
イロン、ポリエステル等の合成繊維などで直接ラビング
してもよく、ポリイミド、ポリアミド等を塗布し、その
面を上記繊維等でラビングしてもよい。ガラスビースな
どのスペーサを配置し、複数枚の支持体を所望の間隔に
制御して対向させ、支持体間に上記組成物を注入し、充
填する。注入された組成物は液晶状態に保持し、分子を
配向させた状態で光重合させる。組成物を液晶状態に保
持するためには、雰囲気温度を融点(Tm )からネマチ
ック−等方相転移温度(Tc )の範囲にすればよいが、
c に近い温度では屈折率異方性が極めて小さいので、
雰囲気温度の上限は(Tc −10)℃以下とするのが好
ましい。光重合開始剤はベンゾインエ−テル類やジアル
コキシフェニルアセトフェノン類等を使用することが好
ましい。光重合開始剤の使用量は、液晶組成物中に、
0.1〜20質量%の範囲内で用いるのが好ましい。
In the case where the liquid crystal composition containing the compound (1) is copolymerized, it is preferable to carry out the copolymerization by irradiation with UV light using an appropriate photopolymerization initiator. At this time, glass, plastic, or the like can be used as the support. The surface of the support may be subjected to an orientation treatment as necessary. The orientation treatment may be performed by directly rubbing the surface of the support with natural fibers such as cotton and wool, synthetic fibers such as nylon and polyester, or applying polyimide or polyamide or the like and rubbing the surface with the above fibers or the like. Good. A spacer such as a glass bead is disposed, a plurality of supports are controlled to face each other at a desired interval, and the composition is injected and filled between the supports. The injected composition is maintained in a liquid crystal state, and is photopolymerized in a state where molecules are oriented. In order to maintain the composition in a liquid crystal state, the ambient temperature may be set in a range from a melting point ( Tm ) to a nematic-isotropic phase transition temperature ( Tc ).
At a temperature close to T c , the refractive index anisotropy is extremely small.
The upper limit of the ambient temperature is preferably (T c -10) ° C. or lower. It is preferable to use benzoin ethers, dialkoxyphenyl acetophenones and the like as the photopolymerization initiator. The amount of the photopolymerization initiator used is, in the liquid crystal composition,
It is preferable to use within the range of 0.1 to 20% by mass.

【0043】化合物(1)を含む本発明の液晶組成物
は、液晶セルに注入する等の方法で、電極付きの基板間
に狭持して液晶素子を構成する。該液晶素子は、高分子
分散型液晶素子、ネマチック型液晶素子、反射コレステ
リック型液晶素子、多色性色素を用いたGH型液晶素
子、強誘電性液晶素子、調光素子、熱線反射フィルム、
光学フィルタ、光学カラーフィルタ、着色フィルム、イ
ンテグレイテッド偏光子、導波管、ビームスプリッタ、
光学グレーティング、光学記録素子、温度指示計等に好
適に用いられる。
The liquid crystal composition of the present invention containing the compound (1) is sandwiched between substrates with electrodes by a method such as injection into a liquid crystal cell to constitute a liquid crystal device. The liquid crystal element is a polymer-dispersed liquid crystal element, a nematic liquid crystal element, a reflective cholesteric liquid crystal element, a GH liquid crystal element using a polychromatic dye, a ferroelectric liquid crystal element, a dimming element, a heat ray reflective film,
Optical filters, optical color filters, colored films, integrated polarizers, waveguides, beam splitters,
It is suitably used for optical gratings, optical recording elements, temperature indicators, and the like.

【0044】また、該液晶組成物を前述のように光重合
して形成される本発明の高分子状物質は、液晶性を有し
ており、高分子分散型液晶素子、アニソトロピックゲ
ル、液晶フィルムなどの種々の用途に好適に用いられ
る。この場合、高分子状物質は支持体に挟んだまま使用
しても、支持体から剥離して使用してもよい。また、本
発明の高分子状物質は、特に硬化性の選択反射を呈する
コレステリック薄膜の形成に好適に用いることができ
る。
The polymer substance of the present invention formed by photopolymerizing the liquid crystal composition as described above has a liquid crystal property, and includes a polymer dispersed liquid crystal element, an anisotropic gel, and a liquid crystal. It is suitably used for various applications such as films. In this case, the polymeric substance may be used while being sandwiched between the supports, or may be used after being separated from the supports. Further, the polymeric substance of the present invention can be suitably used particularly for forming a cholesteric thin film exhibiting curable selective reflection.

【0045】一般的に、光学活性化合物を多量に添加す
ると、低温での保存安定性を悪化させ、粘度や高温での
相転移温度の設計の自由度が小さくなるといった問題が
ある。特に、粘度が高くなると応答速度が低下し、駆動
電圧も高くなるため好ましくない。しかし、本発明の化
合物(1)はらせん誘起力が大きいため、少量の添加で
所望のらせんピッチをもつ液晶組成物が得られる。その
うえ、化合物自体の粘度も低いので、液晶組成物に添加
した場合の粘度上昇が低減でき、低温での保存安定性も
良好である。また、本発明の化合物(1)は光重合性官
能基を有している。本発明の化合物(1)を含む液晶組
成物を光重合して形成される高分子状物質は液晶性を有
しており、これを用いた液晶素子は、偏光板や配向膜を
必要とせず、液晶素子の全体または一部が硬化している
ことにより、液晶配向の安定性が高いので、信頼性の高
い液晶素子を実現できる。
In general, when a large amount of an optically active compound is added, there is a problem that storage stability at a low temperature is deteriorated and the degree of freedom in designing a viscosity and a phase transition temperature at a high temperature is reduced. In particular, when the viscosity is increased, the response speed is reduced, and the driving voltage is also increased, which is not preferable. However, since the compound (1) of the present invention has a large helical inducing force, a liquid crystal composition having a desired helical pitch can be obtained with a small amount of addition. In addition, since the viscosity of the compound itself is low, the rise in viscosity when added to the liquid crystal composition can be reduced, and the storage stability at low temperatures is also good. Further, the compound (1) of the present invention has a photopolymerizable functional group. A polymeric substance formed by photopolymerizing a liquid crystal composition containing the compound (1) of the present invention has liquid crystallinity, and a liquid crystal element using the same does not require a polarizing plate or an alignment film. Since the whole or a part of the liquid crystal element is cured, the stability of the liquid crystal alignment is high, so that a highly reliable liquid crystal element can be realized.

【0046】[0046]

【実施例】以下に、実施例を挙げて本発明をより具体的
に説明する。 [例1](R)−1−(p−クロロフェニル)−2−
(p−(2−メチルプロピル)フェニル)プロパンの合
成例 <第1ステップ>(S)−1−(p−クロロフェニル)
−2−(p−(2−メチルプロピル)フェニル)プロパ
ン−1−オンの合成 1LのナスフラスコAに(S)−2−(p−(2−メチ
ルプロピル)フェニル)プロピオン酸100g(485
mmol)、テトラクロロエチレン400mL、塩化チ
オニル115g(970mmol)、ジメチルアニリン
少量を加え室温で一晩撹拌した後、過剰な塩化チオニ
ル、テトラクロロエチレンを減圧留去し、(S)−2−
(p−(2−メチルプロピル)フェニル)プロピオン酸
クロライド114gを得た。
The present invention will be described below more specifically with reference to examples. [Example 1] (R) -1- (p-chlorophenyl) -2-
Synthesis Example of (p- (2-methylpropyl) phenyl) propane <First Step> (S) -1- (p-chlorophenyl)
Synthesis of 2- (p- (2-methylpropyl) phenyl) propan-1-one 100 g of (S) -2- (p- (2-methylpropyl) phenyl) propionic acid was placed in a 1-L eggplant flask A.
mmol), 400 mL of tetrachloroethylene, 115 g (970 mmol) of thionyl chloride and a small amount of dimethylaniline, and the mixture was stirred at room temperature overnight. Then, excess thionyl chloride and tetrachloroethylene were distilled off under reduced pressure to obtain (S) -2-
114 g of (p- (2-methylpropyl) phenyl) propionic acid chloride were obtained.

【0047】2Lの四ッ口フラスコBに、マグネシウム
片13.0g(533mmol)、無水テトラヒドロフ
ラン50mLと少量のヨウ素粉末を加えた。p−ブロモ
クロロベンゼン92.8g(485mmol)を無水テ
トラヒドロフラン970mLに溶解させた溶液を窒素雰
囲気下で少量滴下し、ヨウ素の色が消えた時点で反応が
開始したとして、反応温度を30℃以下に保ちながら残
りの溶液を1時間で滴下し、滴下終了後室温で2時間撹
拌し、グリニャール試薬を調製した。
To a 2 L four-necked flask B were added 13.0 g (533 mmol) of magnesium pieces, 50 mL of anhydrous tetrahydrofuran and a small amount of iodine powder. A solution prepared by dissolving 92.8 g (485 mmol) of p-bromochlorobenzene in 970 mL of anhydrous tetrahydrofuran was dropped in a small amount under a nitrogen atmosphere, and the reaction was started when the color of iodine disappeared. The remaining solution was added dropwise over 1 hour while stirring, and after completion of the addition, the mixture was stirred at room temperature for 2 hours to prepare a Grignard reagent.

【0048】3Lの四ッ口フラスコCに、フラスコAで
調製した(S)−2−(p−(2−メチルプロピル)フ
ェニル)プロピオン酸クロライド114g、無水テトラ
ヒドロフラン530mLを入れ、窒素雰囲気下で−10
℃に冷却し、鉄(III)アセチルアセトナート171mg
(0.485mmol)を加えた。
In a 3 L four-necked flask C, 114 g of (S) -2- (p- (2-methylpropyl) phenyl) propionic acid chloride prepared in Flask A and 530 mL of anhydrous tetrahydrofuran were added. 10
C. and cooled to 171 mg of iron (III) acetylacetonate.
(0.485 mmol) was added.

【0049】反応温度を0℃以下に保ちながら、フラス
コBで調製したグリニャール試薬を滴下し、滴下終了後
室温まで昇温して2時間撹拌した後、5℃に冷却し、希
塩酸500mLを加えた。有機相を分離し、水相はトル
エンで抽出し、有機相と合わせて水、飽和食塩水で洗浄
し、無水硫酸マグネシウムで乾燥した後、溶媒を留去
し、シリカゲルカラムクロマトグラフィー(展開溶媒=
ヘキサン:トルエン=4:1)で精製し、メタノールか
ら再結晶し、(S)−1−(p−クロロフェニル)−2
−(p−(2−メチルプロピル)フェニル)プロパン−
1−オン[CH3-CH(CH3)-CH2-Ph-C* H(CH3)-CO-Ph-Cl ]
の白色結晶65.6g(218mmol)を得た。(収
率45%)
While maintaining the reaction temperature at 0 ° C. or lower, the Grignard reagent prepared in Flask B was added dropwise. After completion of the addition, the mixture was heated to room temperature, stirred for 2 hours, cooled to 5 ° C., and added with 500 mL of diluted hydrochloric acid. . The organic phase was separated, the aqueous phase was extracted with toluene, combined with the organic phase, washed with water and saturated saline, and dried over anhydrous magnesium sulfate. The solvent was distilled off, and silica gel column chromatography (developing solvent =
Purified with hexane: toluene = 4: 1) and recrystallized from methanol to give (S) -1- (p-chlorophenyl) -2
-(P- (2-methylpropyl) phenyl) propane-
1-one [CH 3 -CH (CH 3) -CH 2 -Ph-C * H (CH 3) -CO-Ph-Cl]
65.6 g (218 mmol) of white crystals were obtained. (Yield 45%)

【0050】[0050]

【表1】 [Table 1]

【0051】<第2ステップ>(R)−1−(p−クロ
ロフェニル)−2−(p−(2−メチルプロピル)フェ
ニル)プロパンの合成 500mLの四ッ口フラスコに、第1ステップで得た
(S)−1−(p−クロロフェニル)−2−(p−(2
−メチルプロピル)フェニル)プロパン−1−オン6
0.0g(199mmol)、トリフルオロ酢酸227
g(1.99mol)を加え、0℃に冷却し、トリエチ
ルシラン58.0g(499mmol)を反応温度を5
℃以下に保ちながら滴下し、滴下終了後室温まで昇温し
て3時間撹拌した。トルエン600mLを加え、減圧下
で溶液量が200mL程度になるまで留去した後、トル
エン400mL加え、5%炭酸水素ナトリウム水溶液、
水、飽和食塩水で洗浄し、無水硫酸マグネシウムで乾燥
した後、溶媒および副生成物を留去し、シリカゲルカラ
ムクロマトグラフィー(展開溶媒=ヘキサン)で精製
し、(R)−1−(p−クロロフェニル)−2−(p−
(2−メチルプロピル)フェニル)プロパン[CH3-CH(C
H3)-CH2-Ph-C* H(CH3)-CH2-Ph-Cl]の無色液体51.4
g(180mmol)を得た。(収率90%)
<Second Step> Synthesis of (R) -1- (p-chlorophenyl) -2- (p- (2-methylpropyl) phenyl) propane Obtained in the first step in a 500 mL four-necked flask. (S) -1- (p-chlorophenyl) -2- (p- (2
-Methylpropyl) phenyl) propan-1-one 6
0.0 g (199 mmol), trifluoroacetic acid 227
g (1.99 mol), the mixture was cooled to 0 ° C., and 58.0 g (499 mmol) of triethylsilane was added at a reaction temperature of 5
The mixture was added dropwise while maintaining the temperature at not more than 0 ° C, and after completion of the addition, the mixture was heated to room temperature and stirred for 3 hours. After adding 600 mL of toluene and distilling off the solution under reduced pressure until the solution volume becomes about 200 mL, 400 mL of toluene is added, and a 5% aqueous sodium hydrogen carbonate solution is added.
After washing with water and saturated saline and drying over anhydrous magnesium sulfate, the solvent and by-products are distilled off, and the residue is purified by silica gel column chromatography (developing solvent = hexane) to give (R) -1- (p- Chlorophenyl) -2- (p-
(2-methylpropyl) phenyl) propane [CH 3 -CH (C
H 3) -CH 2 -Ph-C * H (CH 3) colorless liquid -CH 2 -Ph-Cl] 51.4
g (180 mmol) were obtained. (Yield 90%)

【0052】[0052]

【表2】 [Table 2]

【0053】例1と同様の方法で得られる化合物の具体
例を以下に示す。 CH3-CH(CH3)-CH2-Ph-C* H(CH3)-CH2-Ph-Br H-Ph-C* H(CH3)-CH2-Ph-Cl H-Ph- PhF -C* H(CH3)-CH2-Ph-Cl CH3-O-Ph-C* H(CH3)-CH2-Ph-Cl C6H13- C* H(CH3)-O-Ph- C* H(CH3)-CH2-Ph-Cl CH3-O-Np-C* H(CH3)-CH2-Ph-Cl CH3-CH(CH3)-CH2-Ph-C* H(CH3)-CH2-Ph-Ph-Cl CH3-CH(CH3)-CH2-Ph-C* H(CH3)-CH2-Ph-Ph-Br H-Ph-C* H(CH3)-CH2-Ph-Ph-Cl H-Ph-C* H(CH3)-CH2- PhF -Ph-Cl H-Ph-C* H(CH3)-CH2- PhM -Ph-Cl H-Ph- PhF -C* H(CH3)-CH2-Ph-Ph-Cl CH3-O-Ph-C* H(CH3)-CH2-Ph-Ph-Cl C6H13- C* H(CH3)-O-Ph- C* H(CH3)-CH2-Ph-Ph-Cl CH3-O-Np-C* H(CH3)-CH2-Ph-Ph-Cl
Specific examples of the compounds obtained by the same method as in Example 1 are shown below. CH 3 -CH (CH 3) -CH 2 -Ph-C * H (CH 3) -CH 2 -Ph-Br H-Ph-C * H (CH 3) -CH 2 -Ph-Cl H-Ph- Ph F -C * H (CH 3 ) -CH 2 -Ph-Cl CH 3 -O-Ph-C * H (CH 3 ) -CH 2 -Ph-Cl C 6 H 13 -C * H (CH 3 ) -O-Ph- C * H (CH 3 ) -CH 2 -Ph-Cl CH 3 -O-Np-C * H (CH 3 ) -CH 2 -Ph-Cl CH 3 -CH (CH 3 ) -CH 2 -Ph-C * H (CH 3 ) -CH 2 -Ph-Ph-Cl CH 3 -CH (CH 3 ) -CH 2 -Ph-C * H (CH 3 ) -CH 2 -Ph-Ph-Br H-Ph-C * H (CH 3 ) -CH 2 -Ph-Ph-Cl H-Ph-C * H (CH 3 ) -CH 2 -Ph F -Ph-Cl H-Ph-C * H (CH 3 ) -CH 2 -Ph M -Ph-Cl H-Ph- Ph F -C * H (CH 3 ) -CH 2 -Ph-Ph-Cl CH 3 -O-Ph-C * H (CH 3 )- CH 2 -Ph-Ph-Cl C 6 H 13 -C * H (CH 3 ) -O-Ph- C * H (CH 3 ) -CH 2 -Ph-Ph-Cl CH 3 -O-Np-C * H (CH 3 ) -CH 2 -Ph-Ph-Cl

【0054】[例2](R)−4−(2−(p−(2−
メチルプロピル)フェニル)プロピル)安息香酸の合成
例 500mLの四ッ口フラスコに、マグネシウム片7.4
6g(307mmol)、無水テトラヒドロフラン15
mLと少量のヨウ素粉末を加えた。臭化エチル16.7
g(153mmol)を無水テトラヒドロフラン100
mLに溶解させた溶液を窒素雰囲気下で少量滴下し、ヨ
ウ素の色が消えた時点で反応が開始したとして、反応温
度を25℃以下に保ちながら残りの溶液を1時間で滴下
した。例1で得た(R)−1−(p−クロロフェニル)
−2−(p−(2−メチルプロピル)フェニル)プロパ
ン40.0g(139mmol)を無水テトラヒドロフ
ラン120mLに溶解させた溶液を滴下し、滴下終了
後、加熱環流下で10時間撹拌した。−30℃に冷却
し、−20℃以下に保ちながら炭酸ガスを吹き込み、発
熱が無くなった後に炭酸ガスを吹き込み続けながら室温
まで昇温した。未反応のマグネシウムをろ過した後に、
反応溶液を氷冷した希塩酸に注ぎ、有機相を分離し、水
相をメチル−t−ブチルエーテルで抽出し、有機相とあ
わせて水、飽和食塩水で洗浄し、無水硫酸ナトリウムで
乾燥し、溶媒および副生成物のプロピオン酸を留去して
粗生成物の結晶を得た。これをトルエンから再結晶して
(R)−4−(2−(p−(2−メチルプロピル)フェ
ニル)プロピル)安息香酸[CH3-CH(CH3)-CH2-Ph-C* H
(CH3)-CH2-Ph-COOH]の白色結晶36.0g(121m
mol)を得た(収率87%)。
Example 2 (R) -4- (2- (p- (2-
Example of synthesis of methylpropyl) phenyl) propyl) benzoic acid In a 500 mL four-necked flask, magnesium pieces 7.4 were added.
6 g (307 mmol), anhydrous tetrahydrofuran 15
mL and a small amount of iodine powder were added. Ethyl bromide 16.7
g (153 mmol) in anhydrous tetrahydrofuran 100
A small amount of the solution dissolved in mL was dropped in a nitrogen atmosphere, and the reaction was started when the color of iodine disappeared, and the remaining solution was dropped in 1 hour while maintaining the reaction temperature at 25 ° C or lower. (R) -1- (p-chlorophenyl) obtained in Example 1
A solution obtained by dissolving 40.0 g (139 mmol) of -2- (p- (2-methylpropyl) phenyl) propane in 120 mL of anhydrous tetrahydrofuran was added dropwise, and after completion of the dropwise addition, the mixture was stirred for 10 hours under heated reflux. After cooling to −30 ° C., blowing carbon dioxide gas while keeping the temperature at −20 ° C. or lower, the temperature was raised to room temperature while continuously blowing the carbon dioxide gas after the heat generation disappeared. After filtering unreacted magnesium,
The reaction solution was poured into ice-cooled diluted hydrochloric acid, the organic phase was separated, the aqueous phase was extracted with methyl-t-butyl ether, and the combined organic phase was washed with water and saturated saline, dried over anhydrous sodium sulfate, and dried. The propionic acid as a by-product was distilled off to obtain crystals of a crude product. Which was recrystallized from toluene (R) -4- (2- (p- (2- methylpropyl) phenyl) propyl) benzoic acid [CH 3 -CH (CH 3) -CH 2 -Ph-C * H
(CH 3 ) —CH 2 —Ph-COOH] 36.0 g (121 m
mol) was obtained (yield 87%).

【0055】[0055]

【表3】 [Table 3]

【0056】例2と同様の方法で得られる化合物の具体
例を以下に示す。 H-Ph-C* H(CH3)-CH2-Ph-COOH H-Ph- PhF -C* H(CH3)-CH2-Ph-COOH CH3-O-Ph-C* H(CH3)-CH2-Ph-COOH C6H13- C* H(CH3)-O-Ph- C* H(CH3)-CH2-Ph-COOH CH3-O-Np-C* H(CH3)-CH2-Ph-COOH CH3-CH(CH3)-CH2-Ph-C* H(CH3)-CH2-Ph-Ph-COOH H-Ph-C* H(CH3)-CH2-Ph-Ph-COOH H-Ph-C* H(CH3)-CH2- PhF -Ph-COOH H-Ph-C* H(CH3)-CH2- PhM -Ph-COOH H-Ph- PhF -C* H(CH3)-CH2-Ph-Ph-COOH CH3-O-Ph-C* H(CH3)-CH2-Ph-Ph-COOH C6H13- C* H(CH3)-O-Ph- C* H(CH3)-CH2-Ph-Ph-COOH CH3-O-Np-C* H(CH3)-CH2-Ph-Ph-COOH
Specific examples of the compounds obtained by the same method as in Example 2 are shown below. H-Ph-C * H (CH 3 ) -CH 2 -Ph-COOH H-Ph- Ph F -C * H (CH 3 ) -CH 2 -Ph-COOH CH 3 -O-Ph-C * H ( CH 3 ) -CH 2 -Ph-COOH C 6 H 13 -C * H (CH 3 ) -O-Ph- C * H (CH 3 ) -CH 2 -Ph-COOH CH 3 -O-Np-C * H (CH 3) -CH 2 -Ph -COOH CH 3 -CH (CH 3) -CH 2 -Ph-C * H (CH 3) -CH 2 -Ph-Ph-COOH H-Ph-C * H ( CH 3 ) -CH 2 -Ph-Ph-COOH H-Ph-C * H (CH 3 ) -CH 2 -Ph F -Ph-COOH H-Ph-C * H (CH 3 ) -CH 2 -Ph M -Ph-COOH H-Ph- Ph F -C * H (CH 3 ) -CH 2 -Ph-Ph-COOH CH 3 -O-Ph-C * H (CH 3 ) -CH 2 -Ph-Ph-COOH C 6 H 13 -C * H (CH 3 ) -O-Ph- C * H (CH 3 ) -CH 2 -Ph-Ph-COOH CH 3 -O-Np-C * H (CH 3 ) -CH 2 -Ph-Ph-COOH

【0057】[例3](R)−4−(2−(p−(2−
メチルプロピル)フェニル)プロピル)安息香酸2−ア
クリロイルオキシエチルの合成例 200mLのナスフラスコに例2で合成した、(R)−
4−(2−(p−(2−メチルプロピル)フェニル)プ
ロピル)安息香酸15.0g(50.6mmol)、塩
化チオニル12.0g(101mmol)、テトラクロ
ロエチレン60mL、ジメチルアニリン少量を加え、6
0℃に昇温し、同温で3時間撹拌した後に、過剰な塩化
チオニル、テトラクロロエチレンを減圧留去し、(R)
−4−(2−(p−(2−メチルプロピル)フェニル)
プロピル)安息香酸クロライド16.4gを得た。
Example 3 (R) -4- (2- (p- (2-
Example of synthesis of 2-acryloyloxyethyl methylpropyl) phenyl) propyl) benzoate (R)-synthesized in Example 2 in a 200 mL eggplant flask.
15.0 g (50.6 mmol) of 4- (2- (p- (2-methylpropyl) phenyl) propyl) benzoic acid, 12.0 g (101 mmol) of thionyl chloride, 60 mL of tetrachloroethylene, and a small amount of dimethylaniline were added.
After heating to 0 ° C. and stirring at the same temperature for 3 hours, excess thionyl chloride and tetrachloroethylene were distilled off under reduced pressure, and (R)
-4- (2- (p- (2-methylpropyl) phenyl)
16.4 g of (propyl) benzoic acid chloride were obtained.

【0058】300mLの三ッ口フラスコに(R)−4
−(2−(p−(2−メチルプロピル)フェニル)プロ
ピル)安息香酸クロライド16.4g、アクリル酸2−
ヒドロキシエチル7.64g(65.8mmol)、ジ
クロロメタン150mL、ピリジン4.80g(60.
7mmol)を加え、室温で一晩撹拌した。反応溶液を
水に入れ、有機相を分離し、水相をジクロロメタンで抽
出し、有機相とあわせて希塩酸、水、飽和食塩水で洗浄
し、無水硫酸マグネシウムで乾燥した。p−メトキシフ
ェノールを少量加え、溶媒を留去し、カラムクロマトグ
ラフィー(固定層=シリカゲル:アルミナ=3:1、展
開溶媒=トルエン)で精製し、(R)−4−(2−(p
−(2−メチルプロピル)フェニル)プロピル)安息香
酸2−アクリロイルオキシエチル[CH3-CH(CH3)-CH2-Ph
-C* H(CH3)-CH2-Ph-COO-C2H4-OCO-CH=CH2 ]の無色液体
12.3g(30.9mmol)を得た(収率62
%)。
(R) -4 in a 300 mL three-necked flask
-(2- (p- (2-methylpropyl) phenyl) propyl) benzoic acid chloride 16.4 g, acrylic acid 2-
7.64 g (65.8 mmol) of hydroxyethyl, 150 mL of dichloromethane, 4.80 g of pyridine (60.
7 mmol) and stirred at room temperature overnight. The reaction solution was poured into water, the organic phase was separated, the aqueous phase was extracted with dichloromethane, and the combined organic phase was washed with diluted hydrochloric acid, water, and saturated saline, and dried over anhydrous magnesium sulfate. A small amount of p-methoxyphenol was added, the solvent was distilled off, and the residue was purified by column chromatography (fixed layer = silica gel: alumina = 3: 1, developing solvent = toluene) to give (R) -4- (2- (p
- (2-methylpropyl) phenyl) propyl) 2-acryloyloxyethyl acid [CH 3 -CH (CH 3) -CH 2 -Ph
-C * H (CH 3) to give the -CH 2 -Ph-COO-C 2 H 4 -OCO-CH = CH 2] of a colorless liquid 12.3 g (30.9 mmol) (yield: 62
%).

【0059】[0059]

【表4】 [Table 4]

【0060】[例4](R)−4−(2−(p−(2−
メチルプロピル)フェニル)プロピル)安息香酸4−ア
クリロイルオキシブチルの合成例 200mLのナスフラスコに例2で合成した、(R)−
4−(2−(p−(2−メチルプロピル)フェニル)プ
ロピル)安息香酸15.0g(50.6mmol)、塩
化チオニル12.0g(101mmol)、テトラクロ
ロエチレン60mL、ジメチルアニリン少量を加え、6
0℃に昇温し、同温で3時間撹拌した後に、過剰な塩化
チオニル、テトラクロロエチレンを減圧留去し、(R)
−4−(2−(p−(2−メチルプロピル)フェニル)
プロピル)安息香酸クロライド16.5gを得た。
Example 4 (R) -4- (2- (p- (2-
Synthesis Example of 4-Acryloyloxybutyl Methylpropyl) phenyl) propyl) benzoate (R)-synthesized in Example 2 in a 200 mL eggplant flask.
15.0 g (50.6 mmol) of 4- (2- (p- (2-methylpropyl) phenyl) propyl) benzoic acid, 12.0 g (101 mmol) of thionyl chloride, 60 mL of tetrachloroethylene, and a small amount of dimethylaniline were added.
After heating to 0 ° C. and stirring at the same temperature for 3 hours, excess thionyl chloride and tetrachloroethylene were distilled off under reduced pressure, and (R)
-4- (2- (p- (2-methylpropyl) phenyl)
16.5 g of propyl) benzoic acid chloride were obtained.

【0061】300mLの三ッ口フラスコに(R)−4
−(2−(p−(2−メチルプロピル)フェニル)プロ
ピル)安息香酸クロライド16.5g、アクリル酸4−
ヒドロキシブチル9.48g(65.8mmol)、ジ
クロロメタン150mL、ピリジン4.80g(60.
7mmol)を加え、室温で一晩撹拌した。反応溶液を
水に入れ、有機相を分離し、水相をジクロロメタンで抽
出し、有機相とあわせて希塩酸、水、飽和食塩水で洗浄
し、無水硫酸マグネシウムで乾燥した。p−メトキシフ
ェノールを少量加え、溶媒を留去し、カラムクロマトグ
ラフィー(固定層=シリカゲル:アルミナ=2:1、展
開溶媒=トルエン)で精製し、(R)−4−(2−(p
−(2−メチルプロピル)フェニル)プロピル)安息香
酸4−アクリロイルオキシブチル[CH3-CH(CH3)-CH2-Ph
-C* H(CH3)-CH2-Ph-COO-C4H8-OCO-CH=CH2 ]の無色液体
16.5g(39.0mmol)を得た(収率77
%)。
(R) -4 in a 300 mL three-necked flask
-(2- (p- (2-methylpropyl) phenyl) propyl) benzoic acid chloride 16.5 g, acrylic acid 4-
9.48 g (65.8 mmol) of hydroxybutyl, 150 mL of dichloromethane, 4.80 g of pyridine (60.
7 mmol) and stirred at room temperature overnight. The reaction solution was poured into water, the organic phase was separated, the aqueous phase was extracted with dichloromethane, and the combined organic phase was washed with diluted hydrochloric acid, water, and saturated saline, and dried over anhydrous magnesium sulfate. A small amount of p-methoxyphenol was added, the solvent was distilled off, and the residue was purified by column chromatography (fixed layer = silica gel: alumina = 2: 1, developing solvent = toluene), and (R) -4- (2- (p
- (2-methylpropyl) phenyl) propyl) benzoic acid 4-acryloyloxy-butyl [CH 3 -CH (CH 3) -CH 2 -Ph
-C * H (CH 3) to give the -CH 2 -Ph-COO-C 4 H 8 -OCO-CH = CH 2] of a colorless liquid 16.5 g (39.0 mmol) (yield: 77
%).

【0062】[0062]

【表5】 [Table 5]

【0063】例3および例4と同様の方法で得られる化
合物の具体例を以下に示す。 CH3-CH(CH3)-CH2-Ph-C* H(CH3)-CH2-Ph-COO-C6H12-OCO-
CH=CH2 CH3-CH(CH3)-CH2-Ph-C* H(CH3)-CH2-Ph-COO-C11H22-OCO
-CH=CH2 CH3-CH(CH3)-CH2-Ph-C* H(CH3)-CH2-Ph-COO-C6H12-OCO-
C(CH3)=CH2 CH3-CH(CH3)-CH2-Ph-C* H(CH3)-CH2-Ph-COO-C11H22-OCO
-C(CH3)=CH2 H-Ph-C* H(CH3)-CH2-Ph-COO-C2H4-OCO-CH=CH2 H-Ph-C* H(CH3)-CH2-Ph-COO-C4H8-OCO-CH=CH2 H-Ph-C* H(CH3)-CH2-Ph-COO-C6H12-OCO-CH=CH2 H-Ph-C* H(CH3)-CH2-Ph-COO-C11H22-OCO-CH=CH2 H-Ph-C* H(CH3)-CH2-Ph-COO-C6H12-OCO-C(CH3)=CH2 H-Ph-C* H(CH3)-CH2-Ph-COO-C11H22-OCO-C(CH3)=CH2 H-Ph- PhF -C* H(CH3)-CH2-Ph-COO-C6H12-OCO-CH=CH2 CH3-O-Ph-C* H(CH3)-CH2-Ph-COO-C6H12-OCO-CH=CH2 C6H13- C* H(CH3)-O-Ph- C* H(CH3)-CH2-Ph-COO-C6H12-
OCO-CH=CH2 CH3-O-Np-C* H(CH3)-CH2-Ph-COO-C6H12-OCO-CH=CH2 CH3-CH(CH3)-CH2-Ph-C* H(CH3)-CH2-Ph-Ph-COO-C6H12-O
CO-CH=CH2 H-Ph-C* H(CH3)-CH2-Ph-Ph-COO-C6H12-OCO-CH=CH2 H-Ph-C* H(CH3)-CH2-Np-COO-C6H12-OCO-CH=CH2
Specific examples of the compounds obtained in the same manner as in Examples 3 and 4 are shown below. CH 3 -CH (CH 3 ) -CH 2 -Ph-C * H (CH 3 ) -CH 2 -Ph-COO-C 6 H 12 -OCO-
CH = CH 2 CH 3 -CH (CH 3 ) -CH 2 -Ph-C * H (CH 3 ) -CH 2 -Ph-COO-C 11 H 22 -OCO
-CH = CH 2 CH 3 -CH (CH 3 ) -CH 2 -Ph-C * H (CH 3 ) -CH 2 -Ph-COO-C 6 H 12 -OCO-
C (CH 3 ) = CH 2 CH 3 -CH (CH 3 ) -CH 2 -Ph-C * H (CH 3 ) -CH 2 -Ph-COO-C 11 H 22 -OCO
-C (CH 3 ) = CH 2 H-Ph-C * H (CH 3 ) -CH 2 -Ph-COO-C 2 H 4 -OCO-CH = CH 2 H-Ph-C * H (CH 3 ) -CH 2 -Ph-COO-C 4 H 8 -OCO-CH = CH 2 H-Ph-C * H (CH 3 ) -CH 2 -Ph-COO-C 6 H 12 -OCO-CH = CH 2 H -Ph-C * H (CH 3 ) -CH 2 -Ph-COO-C 11 H 22 -OCO-CH = CH 2 H-Ph-C * H (CH 3) -CH 2 -Ph-COO-C 6 H 12 -OCO-C (CH 3 ) = CH 2 H-Ph-C * H (CH 3 ) -CH 2 -Ph-COO-C 11 H 22 -OCO-C (CH 3 ) = CH 2 H-Ph -Ph F -C * H (CH 3 ) -CH 2 -Ph-COO-C 6 H 12 -OCO-CH = CH 2 CH 3 -O-Ph-C * H (CH 3 ) -CH 2 -Ph- COO-C 6 H 12 -OCO- CH = CH 2 C 6 H 13 - C * H (CH 3) -O-Ph- C * H (CH 3) -CH 2 -Ph-COO-C 6 H 12 -
OCO-CH = CH 2 CH 3 -O-Np-C * H (CH 3 ) -CH 2 -Ph-COO-C 6 H 12 -OCO-CH = CH 2 CH 3 -CH (CH 3 ) -CH 2 -Ph-C * H (CH 3 ) -CH 2 -Ph-Ph-COO-C 6 H 12 -O
CO-CH = CH 2 H-Ph-C * H (CH 3 ) -CH 2 -Ph-Ph-COO-C 6 H 12 -OCO-CH = CH 2 H-Ph-C * H (CH 3 )- CH 2 -Np-COO-C 6 H 12 -OCO-CH = CH 2

【0064】[例5]メルク社製液晶組成物(商品名:
ZLI−1565)の100質量部に、例3で合成した
(R)−4−(2−(p−(2−メチルプロピル)フェ
ニル)プロピル)安息香酸2−アクリロイルオキシエチ
ルを1質量部(組成物中に含まれる光学活性化合物の質
量%;c=0.01)加え液晶組成物(SA )を、例4
で合成した(R)−4−(2−(p−(2−メチルプロ
ピル)フェニル)プロピル)安息香酸4−アクリロイル
オキシブチルを1質量部(c=0.01)加え液晶組成
物(SB )を得た。メルク社製液晶組成物(商品名:Z
LI−1565)の100質量部に、市販のカイラル剤
である前記化合物(CN)を1質量部(c=0.01)
加え液晶組成物(SC )を得た。得られた液晶組成物
(SA )、(SB )および(SC )について、25℃に
おけるヘリカルピッチ長P(m)をカノー(Cano)
ウェッジ法にて測定し、それぞれの光学活性化合物のら
せん誘起力(HTP)を下式より求めた。また、らせん
誘起の向きは接触法により測定した。結果を表1に示
す。 らせん誘起力:HTP=1/(P・c)
Example 5 A liquid crystal composition manufactured by Merck (trade name:
(ZLI-1565) and 100 parts by mass of 2-acryloyloxyethyl (R) -4- (2- (p- (2-methylpropyl) phenyl) propyl) benzoate synthesized in Example 3 (composition) % By mass of the optically active compound contained in the substance; c = 0.01) and the liquid crystal composition (S A ) was prepared in Example 4.
The liquid crystal composition (S B ) was added with 1 part by mass (c = 0.01) of 4-acryloyloxybutyl (R) -4- (2- (p- (2-methylpropyl) phenyl) propyl) benzoate synthesized in (1). ) Got. Liquid crystal composition manufactured by Merck (trade name: Z
LI-1565) and 100 parts by mass of the compound (CN), which is a commercially available chiral agent, is 1 part by mass (c = 0.01).
In addition, a liquid crystal composition (S C ) was obtained. For the obtained liquid crystal compositions (S A ), (S B ) and (S C ), the helical pitch length P (m) at 25 ° C.
The helix inducing force (HTP) of each optically active compound was determined by the following formula by measuring by the wedge method. The direction of helix induction was measured by the contact method. Table 1 shows the results. Helix inducing force: HTP = 1 / (P · c)

【0065】[0065]

【表6】 本発明の光学活性化合物のらせん誘起力は、市販のカイ
ラル剤に比べて大きかった。
[Table 6] The helix-inducing power of the optically active compound of the present invention was larger than that of a commercially available chiral agent.

【0066】[0066]

【発明の効果】本発明の化合物(1)〜(3)は光学活
性を有する物質である。本発明の化合物(1)はらせん
誘起力が大きいため、従来の光学活性化合物より少量の
添加で、目的とするらせんピッチを持つ液晶組成物を得
ることが可能である。また、本発明の化合物(1)は共
重合可能な光学活性化合物である。そのため、本発明の
化合物(1)を添加した液晶組成物は、高分子分散型液
晶素子、アニソトロピックゲル、液晶フィルム等に用い
る液晶組成物として有用である。また、本発明の製造方
法により、上記化合物を安価に高収率で製造することが
可能となる。
The compounds (1) to (3) of the present invention are optically active substances. Since the compound (1) of the present invention has a large helical inducing force, it is possible to obtain a liquid crystal composition having a desired helical pitch by adding a smaller amount than a conventional optically active compound. The compound (1) of the present invention is a copolymerizable optically active compound. Therefore, the liquid crystal composition to which the compound (1) of the present invention is added is useful as a liquid crystal composition used for a polymer-dispersed liquid crystal device, an anisotropic gel, a liquid crystal film, and the like. In addition, the production method of the present invention makes it possible to produce the above compound at low cost and in high yield.

───────────────────────────────────────────────────── フロントページの続き (51)Int.Cl.7 識別記号 FI テーマコート゛(参考) C08F 20/26 C08F 20/26 C09K 19/38 C09K 19/38 19/54 19/54 B G02F 1/13 500 G02F 1/13 500 // C07M 7:00 C07M 7:00 (72)発明者 小池 毅 神奈川県茅ヶ崎市茅ヶ崎3丁目2番10号 セイミケミカル株式会社内 (72)発明者 横小路 修 神奈川県茅ヶ崎市茅ヶ崎3丁目2番10号 セイミケミカル株式会社内 (72)発明者 新山 聡 神奈川県横浜市神奈川区羽沢町1150番地 旭硝子株式会社内 (72)発明者 田原 慎哉 神奈川県横浜市神奈川区羽沢町1150番地 旭硝子株式会社内 Fターム(参考) 4H006 AA01 AA02 AB64 AC46 AC48 BE90 BJ50 BS10 BS30 KA14 4H027 BA11 BB11 BD03 BD16 4J100 AL08P BA02P BA15P BB07P BB12P BB18P BC04P BC43P BC49P CA01 CA04 DA66 JA32 JA39 ──────────────────────────────────────────────────の Continued on the front page (51) Int.Cl. 7 Identification code FI Theme coat ゛ (Reference) C08F 20/26 C08F 20/26 C09K 19/38 C09K 19/38 19/54 19/54 B G02F 1/13 500 G02F 1/13 500 // C07M 7:00 C07M 7:00 (72) Inventor Takeshi Koike 3-2-1-10 Chigasaki, Chigasaki City, Kanagawa Prefecture Inside Seimi Chemical Co., Ltd. (72) Inventor Osamu Yokokoji Chigasaki, Kanagawa Prefecture 3-2-10, Chigasaki, Seimi Chemical Co., Ltd. Address Asahi Glass Co., Ltd. F-term (reference) 4H006 AA01 AA02 AB64 AC46 AC48 BE90 BJ50 BS10 BS30 KA14 4H027 BA11 BB11 BD03 BD16 4J100 AL 08P BA02P BA15P BB07P BB12P BB18P BC04P BC43P BC49P CA01 CA04 DA66 JA32 JA39

Claims (9)

【特許請求の範囲】[Claims] 【請求項1】下式(1)で表される光学活性化合物。 R-X1-A1-B1-C* HY1-CH2-(B2)n -X2-A2-X3-A3-X4-Z-OCO-CY2=CH2 …式(1) ただし、式(1)中の記号は下記の意味を示す。 R:炭素数1〜12のアルキル基、水素原子の1個以上
がフッ素原子に置換された炭素数1〜12のアルキル
基、水素原子またはハロゲン原子。X1 、X2 、X3
4 :相互に独立して、カルボニルオキシ基(−COO
−)、オキシカルボニル基(−OCO−)、エーテル性
の酸素原子(−O−)、オキシメチレン基(−OCH2
−)、メチレンオキシ基(−CH2 O−)または単結
合。 Y1 :メチル基(−CH3 )または水素原子の1個以上
がフッ素原子に置換されたメチル基。 Y2 :水素原子またはメチル基(−CH3 )。 Z:炭素数1〜12のアルキレン基または水素原子の1
個以上がフッ素原子に置換された炭素数1〜12のアル
キレン基。 A1 、A2 、A3 :相互に独立して、水素原子の1個ま
たは2個がフッ素原子に置換されていてもよい1,4−
フェニレン基、水素原子の1個または2個がメチル基
(−CH3 )に置換されていてもよい1,4−フェニレ
ン基、非置換の2,6−ナフチレン基、非置換のトラン
ス−1,4−シクロヘキシレン基または単結合。 B1 、B2 :相互に独立して、水素原子の1個もしくは
2個がフッ素原子に置換されていてもよい1,4−フェ
ニレン基、水素原子の1個もしくは2個がメチル基(−
CH3 )に置換されていてもよい1,4−フェニレン
基、非置換の2,6−ナフチレン基、非置換のトランス
−1,4−シクロヘキシレン基または−D 1 −CH2
2 −D2 −で表される基(D1 およびD2 はそれぞれ
独立に、水素原子の1個または2個がフッ素原子および
/またはメチル基(−CH3 )に置換されていてもよい
1,4−フェニレン基、非置換の2,6−ナフチレン
基、非置換のトランス−1,4−シクロヘキシレン基を
表す。)。 n:1または2。 C* :不斉炭素原子。
1. An optically active compound represented by the following formula (1). R-X1-A1-B1-C*HY1-CHTwo-(BTwo)n-XTwo-ATwo-XThree-AThree-XFour-Z-OCO-CYTwo= CHTwo ... Formula (1) However, the symbol in Formula (1) has the following meaning. R: an alkyl group having 1 to 12 carbon atoms, at least one hydrogen atom
Is a C1-C12 alkyl substituted with a fluorine atom
Group, hydrogen atom or halogen atom. X1, XTwo, XThree,
XFour: Independently of each other, a carbonyloxy group (—COO
-), Oxycarbonyl group (-OCO-), etheric
Oxygen atom (-O-), oxymethylene group (-OCHTwo
-), Methyleneoxy group (-CHTwoO-) or single bond
Go. Y1: Methyl group (-CHThree) Or one or more hydrogen atoms
Is a methyl group substituted by a fluorine atom. YTwo: Hydrogen atom or methyl group (-CHThree). Z: one of an alkylene group having 1 to 12 carbon atoms or a hydrogen atom
Having 1 to 12 carbon atoms in which at least one is substituted with a fluorine atom
Kilen group. A1, ATwo, AThree: Up to one hydrogen atom independently of each other
Or two of which may be substituted with a fluorine atom
Phenylene group, one or two hydrogen atoms are methyl groups
(-CHThree1,4-phenylene optionally substituted by
Group, unsubstituted 2,6-naphthylene group, unsubstituted
1,4-cyclohexylene group or single bond. B1, BTwo: Independently of one another,
1,4-phenyl optionally substituted by two fluorine atoms
Nylene group, one or two hydrogen atoms are methyl group (-
CHThree1,4-phenylene optionally substituted by
Group, unsubstituted 2,6-naphthylene group, unsubstituted trans
-1,4-cyclohexylene group or -D 1-CHTwoC
HTwo-DTwoA group represented by-(D1And DTwoAre each
Independently, one or two of the hydrogen atoms are a fluorine atom and
And / or methyl group (-CHThree) May be substituted
1,4-phenylene group, unsubstituted 2,6-naphthylene
Group, unsubstituted trans-1,4-cyclohexylene group
Represent. ). n: 1 or 2. C*: Asymmetric carbon atom.
【請求項2】式(1)で表される化合物が下式(2)で
表される化合物である請求項1に記載の光学活性化合
物。 R-X1-A1-B1-C* HY1-CH2-(B2)n -COO-A2-X3-A3-X4-Z-OCO-CY2=CH2 …式(2) ただし、式(2)中の記号R、X1 、X3 、X4
1 、Y2 、Z、A1 、A2、A3 、B1 、B2 、nお
よびC* は式(1)におけるものと同じ意味を示す。
2. The optically active compound according to claim 1, wherein the compound represented by the formula (1) is a compound represented by the following formula (2). RX 1 -A 1 -B 1 -C * HY 1 -CH 2- (B 2 ) n -COO-A 2 -X 3 -A 3 -X 4 -Z-OCO-CY 2 = CH 2 … Formula (2) Where the symbols R, X 1 , X 3 , X 4 ,
Y 1 , Y 2 , Z, A 1 , A 2 , A 3 , B 1 , B 2 , n and C * have the same meanings as in formula (1).
【請求項3】下式(3)で表される光学活性化合物。 R-X1-A1-B1-C* HY1-CH2-(B2)n -COOH …式(3) ただし、式(3)中の記号R、X1 、Y1 、A1
1 、B2 、nおよびC* は式(1)におけるものと同
じ意味を示す。
3. An optically active compound represented by the following formula (3). RX 1 -A 1 -B 1 -C * HY 1 -CH 2- (B 2 ) n -COOH Formula (3) where symbols R, X 1 , Y 1 , A 1 ,
B 1 , B 2 , n and C * have the same meaning as in formula (1).
【請求項4】下記の工程(a)および工程(b)を経由
する式(3)で表される光学活性化合物の製造方法。 工程(a):下式(4)で表されるカルボン酸を酸クロ
ライドとし、下式(5)で表されるグリニャール試薬と
カップリング反応させ、生成した下式(6)で表される
ケトンを還元し、下式(7)で表される光学活性化合物
とする工程。 工程(b):下式(7)で表される光学活性化合物を下
式(8)で表されるグリニャール試薬とし、二酸化炭素
と反応させる工程。 R-X1-A1-B1-C* HY1-COOH …式(4) Q'-Mg-(B2)n -Q …式(5) R-X1-A1-B1-C* HY1-CO- (B2)n -Q …式(6) R-X1-A1-B1-C* HY1-CH2-(B2)n -Q …式(7) R-X1-A1-B1-C* HY1-CH2-(B2)n -Mg-Q …式(8) ただし、式(4)、(5)、(6)、(7)および
(8)中のR、X1 、Y1 、A1 、B1 、B2 、nおよ
びC* は、式(3)におけるものと同じ意味を示し、Q
およびQ’は下記の意味を示す。 Q:ハロゲン原子。 Q’:臭素原子またはヨウ素原子。 ただし、Q’が臭素原子の場合、Qはヨウ素原子ではな
い。
4. A method for producing an optically active compound represented by the formula (3) via the following steps (a) and (b). Step (a): A carboxylic acid represented by the following formula (4) is converted to an acid chloride, and a coupling reaction is performed with a Grignard reagent represented by the following formula (5) to produce a ketone represented by the following formula (6): To obtain an optically active compound represented by the following formula (7). Step (b): a step of converting an optically active compound represented by the following formula (7) into a Grignard reagent represented by the following formula (8) and reacting with carbon dioxide. RX 1 -A 1 -B 1 -C * HY 1 -COOH ... Equation (4) Q'-Mg- (B 2 ) n -Q ... Equation (5) RX 1 -A 1 -B 1 -C * HY 1 -CO- (B 2 ) n -Q… Equation (6) RX 1 -A 1 -B 1 -C * HY 1 -CH 2- (B 2 ) n -Q… Equation (7) RX 1 -A 1- B 1 -C * HY 1 -CH 2- (B 2 ) n -Mg-Q where R in the formulas (4), (5), (6), (7) and (8) , X 1 , Y 1 , A 1 , B 1 , B 2 , n and C * have the same meanings as in formula (3),
And Q ′ have the following meanings. Q: a halogen atom. Q ′: a bromine atom or an iodine atom. However, when Q ′ is a bromine atom, Q is not an iodine atom.
【請求項5】式(3)で表される光学活性化合物を酸ク
ロライドとし、下式(9)で表されるアルコールと反応
させることを特徴とする、式(2)で表される光学活性
化合物の製造方法。 HO-A2-X3-A3-X4-Z-OCO-CY2=CH2 …式(9) ただし、式(9)中のX3 、X4 、A2 、A3 、Y2
よびZは式(2)におけるものと同じ意味を示す。
5. An optically active compound represented by the formula (2), wherein the optically active compound represented by the formula (3) is converted to an acid chloride and reacted with an alcohol represented by the following formula (9). A method for producing a compound. HO-A 2 -X 3 -A 3 -X 4 -Z-OCO-CY 2 = CH 2 Formula (9) where X 3 , X 4 , A 2 , A 3 and Y 2 in the formula (9) And Z have the same meaning as in formula (2).
【請求項6】請求項1または2に記載の光学活性化合物
の1種以上を、合量で0.1〜80質量%含有する液晶
組成物。
6. A liquid crystal composition containing at least one of the optically active compounds according to claim 1 or 2 in a total amount of 0.1 to 80% by mass.
【請求項7】請求項1または2に記載の光学活性化合物
の1種以上を共重合させた高分子状物質。
7. A high molecular substance obtained by copolymerizing at least one of the optically active compounds according to claim 1 or 2.
【請求項8】請求項6に記載の液晶組成物を用いた液晶
素子。
8. A liquid crystal device using the liquid crystal composition according to claim 6.
【請求項9】請求項7に記載の高分子状物質を用いた液
晶素子。
9. A liquid crystal device using the polymeric substance according to claim 7.
JP2001131178A 2000-04-28 2001-04-27 Optically active compound, method for producing the same, liquid crystal composition containing the same, and liquid crystal element Expired - Fee Related JP4849732B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2001131178A JP4849732B2 (en) 2000-04-28 2001-04-27 Optically active compound, method for producing the same, liquid crystal composition containing the same, and liquid crystal element

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP2000131236 2000-04-28
JP2000131236 2000-04-28
JP2000-131236 2000-04-28
JP2001131178A JP4849732B2 (en) 2000-04-28 2001-04-27 Optically active compound, method for producing the same, liquid crystal composition containing the same, and liquid crystal element

Publications (2)

Publication Number Publication Date
JP2002012580A true JP2002012580A (en) 2002-01-15
JP4849732B2 JP4849732B2 (en) 2012-01-11

Family

ID=26591272

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2001131178A Expired - Fee Related JP4849732B2 (en) 2000-04-28 2001-04-27 Optically active compound, method for producing the same, liquid crystal composition containing the same, and liquid crystal element

Country Status (1)

Country Link
JP (1) JP4849732B2 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005023019A (en) * 2003-07-02 2005-01-27 Chisso Corp Liquid crystalline compounds and polymers having optically active groups
CN102876332A (en) * 2012-09-05 2013-01-16 北京八亿时空液晶科技股份有限公司 Liquid crystal compound and application thereof

Citations (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH02202981A (en) * 1989-02-02 1990-08-13 Idemitsu Kosan Co Ltd Ferroelectric liquid crystal composition
JPH02206682A (en) * 1989-02-06 1990-08-16 Idemitsu Kosan Co Ltd liquid crystal composition
JPH05196815A (en) * 1992-01-22 1993-08-06 Seiko Epson Corp Optically anisotropic body, method for producing optically anisotropic body, and liquid crystal device provided with optically anisotropic body
EP0590376A1 (en) * 1992-09-19 1994-04-06 MERCK PATENT GmbH Polymeric composite material
JPH0753861A (en) * 1993-08-17 1995-02-28 Ube Ind Ltd Resin composition for automobile cooling system parts
JPH07206770A (en) * 1994-01-26 1995-08-08 Sanyo Chem Ind Ltd (meth)acrylic ester
JPH0841461A (en) * 1994-07-26 1996-02-13 Dainippon Ink & Chem Inc Polymerizable liquid crystal composition
JPH08245960A (en) * 1995-01-13 1996-09-24 Dainippon Ink & Chem Inc Liquid crystal composition
JPH0912485A (en) * 1995-06-28 1997-01-14 Dainippon Ink & Chem Inc 4- (2-cyclohexylpropyl) benzene derivative
JPH0930995A (en) * 1995-07-21 1997-02-04 Dainippon Ink & Chem Inc 1,2-dicyclohexylpropane derivative
JPH09302344A (en) * 1996-05-10 1997-11-25 Chisso Corp Liquid crystal composition and liquid crystal display element
JPH1077249A (en) * 1996-09-05 1998-03-24 Sharp Corp Polymerizable compound, polymerizable composition, and liquid crystal display device using the same

Patent Citations (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH02202981A (en) * 1989-02-02 1990-08-13 Idemitsu Kosan Co Ltd Ferroelectric liquid crystal composition
JPH02206682A (en) * 1989-02-06 1990-08-16 Idemitsu Kosan Co Ltd liquid crystal composition
JPH05196815A (en) * 1992-01-22 1993-08-06 Seiko Epson Corp Optically anisotropic body, method for producing optically anisotropic body, and liquid crystal device provided with optically anisotropic body
EP0590376A1 (en) * 1992-09-19 1994-04-06 MERCK PATENT GmbH Polymeric composite material
JPH0753861A (en) * 1993-08-17 1995-02-28 Ube Ind Ltd Resin composition for automobile cooling system parts
JPH07206770A (en) * 1994-01-26 1995-08-08 Sanyo Chem Ind Ltd (meth)acrylic ester
JPH0841461A (en) * 1994-07-26 1996-02-13 Dainippon Ink & Chem Inc Polymerizable liquid crystal composition
JPH08245960A (en) * 1995-01-13 1996-09-24 Dainippon Ink & Chem Inc Liquid crystal composition
JPH0912485A (en) * 1995-06-28 1997-01-14 Dainippon Ink & Chem Inc 4- (2-cyclohexylpropyl) benzene derivative
JPH0930995A (en) * 1995-07-21 1997-02-04 Dainippon Ink & Chem Inc 1,2-dicyclohexylpropane derivative
JPH09302344A (en) * 1996-05-10 1997-11-25 Chisso Corp Liquid crystal composition and liquid crystal display element
JPH1077249A (en) * 1996-09-05 1998-03-24 Sharp Corp Polymerizable compound, polymerizable composition, and liquid crystal display device using the same

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005023019A (en) * 2003-07-02 2005-01-27 Chisso Corp Liquid crystalline compounds and polymers having optically active groups
CN102876332A (en) * 2012-09-05 2013-01-16 北京八亿时空液晶科技股份有限公司 Liquid crystal compound and application thereof

Also Published As

Publication number Publication date
JP4849732B2 (en) 2012-01-11

Similar Documents

Publication Publication Date Title
EP1187802B1 (en) Liquid crystal compounds
JP4058481B2 (en) Polymerizable liquid crystal compound and optical film
JP5880992B2 (en) Polymerizable compound and liquid crystal composition using the same
JP4058480B2 (en) Liquid crystalline (meth) acrylate compound, liquid crystal composition containing the compound, and optical film using them
JP2000178233A (en) Liquid crystal (meth) acrylate compound, liquid crystal composition containing the compound, and optically anisotropic substance using the same
JP4577990B2 (en) Liquid crystal compound
Hu et al. Side-chain cholesteric liquid crystalline elastomers derived from a mesogenic cross-linking agent
JP2011184417A (en) Polymerizable acetylene compound
JP6308415B2 (en) Polymerizable compound and liquid crystal composition using the same
JP3601069B2 (en) Terphenyl methacrylate derivative
JP5545516B2 (en) Polymerizable compound
JP4506232B2 (en) Polymerizable liquid crystal compound, liquid crystal composition containing the same, and polymers thereof
JP4524827B2 (en) Acrylic acid derivative compound
JP4849732B2 (en) Optically active compound, method for producing the same, liquid crystal composition containing the same, and liquid crystal element
JP3838366B2 (en) Liquid crystal element
JP4088339B2 (en) Novel chiral cyclohexyl compounds
JP2003313250A (en) Polymerizable liquid crystal composition and optically anisotropic body
JP4573409B2 (en) Optically active compound, liquid crystal composition containing the same, and liquid crystal element
JP2002234853A (en) Optically active compound, liquid crystal composition containing the same and liquid crystal device
JP3632220B2 (en) Novel polymerizable compound and polymerizable liquid crystal composition
JP4803626B2 (en) Polymerizable liquid crystal compound
JP4911335B2 (en) Polymer-dispersed liquid crystal display element composition and polymer-dispersed liquid crystal display element
JP4029528B2 (en) Acrylic acid derivative compound, polymer liquid crystal obtained by polymerizing the same, and use thereof
JP4764557B2 (en) Optically active compound, liquid crystal composition containing the same, and liquid crystal element
JP2004323729A (en) Polymerizable liquid crystal composition and optically anisotropic body

Legal Events

Date Code Title Description
A711 Notification of change in applicant

Free format text: JAPANESE INTERMEDIATE CODE: A711

Effective date: 20080310

RD04 Notification of resignation of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7424

Effective date: 20080311

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20080318

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20080310

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20110420

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20110426

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20110623

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20110712

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20110907

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20111004

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20111018

R150 Certificate of patent or registration of utility model

Free format text: JAPANESE INTERMEDIATE CODE: R150

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20141028

Year of fee payment: 3

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

LAPS Cancellation because of no payment of annual fees